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ABSTRACT 
 
Lung development is a complex process that involves a coordinated 
orchestration of several signalling pathways and mechanisms in order to 
growth normally. Pulmonary hypoplasia emerges as a result of foetal 
abnormal lung development and consequently it leads to high rates of 
morbidity and mortality. The understanding of normal and abnormal foetal 
lung growth has became clinical relevant because it can offer new 
perspectives in the treatment of lung diseases. Regardless the recent 
advances in the knowledge of lung development, there are still a lot of 
mechanisms that need to be elucidated and investigated.  
The main aim of this PhD dissertation was to investigate new 
physiological regulators of foetal lung growth in order to find a prenatal 
therapy to revert foetal lung hypoplasia in Congenital Diaphragmatic Hernia 
(CDH) context. Moreover, two already well-known and studied signalling 
pathways (retinoic acid and neuroendocrine factors) were further investigated 
and an important link between them was discovered/established. Using 
molecular/histological techniques and gain-loss of function studies with 
nitrofen rat model and human samples we tried to achieve our goals. 
In this PhD thesis, it was demonstrated that ephrins B1, -B2 and eph B4 
receptor were expressed during all foetal lung developmental stages. 
Moreover ephrin B1 and eph B4 receptor mainly presented mesenchymal 
expressions whereas ephrin B2 presented an epithelial expression. Ephrin 
B1 and –B2 administration contributed to increase foetal lung branching, but 
the observed increase has not significant biological meaning. Another 
interesting finding was the importance of microRNAs in human CDH. 
MicroRNA 10a and microRNA 200b are up-regulated in CDH human lungs 
when compared to normal lungs and they are also changed in the tracheal 
fluid of CDH babies that respond or did not respond to FETO. In FETO 
responders, after removing the plug, tracheal fluid presented higher 
expression of miR-10a and miR-200 family when compared to non-
responders. Moreover, in responders the expression of those microRNAs 
increased significantly after removing the plug when compared to the 
expression observed at the moment of plug insertion. In line with the second 
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aim mentioned above, we decided to look into two already known and 
apparently unrelated signalling pathways and discover a link between them 
because both of them are altered in CDH (retinoic acid was down-regulated 
and neuroendocrine factors were up-regulated). We found that 
neuroendocrine factors act as regulators of lung growth, sensitizing the lungs 
to the action of retinoic acid through RAR α and RAR γ up-regulation.  
To conclude, in this thesis, we showed that ephrins seem to be strong 
candidates to act as morphogens or being involved in vascular regulation 
instead of being a promisor mechanism to regulate lung growth. Additionally, 
we discovered that microRNAs are an important tool as a prognostic 
biomarker for CDH new-borns outcome. Moreover, we established a novel 
physiological link showing that neuroendocrine factors and retinoic acid 
signalling pathways interact with each other during foetal lung growth 
regulation. With this work, new insights into normal and abnormal foetal lung 
development were brought, discovering novel mechanisms to further explore 
as potential therapeutic targets into CDH field. 
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RESUMO 
 
O desenvolvimento pulmonar é um processo complexo que envolve a 
combinação e funcionamento coordenados de várias vias e mecanismos de 
sinalização, a fim do crescimento pulmonar normal. A hipoplasia pulmonar 
surge como resultado do desenvolvimento anormal do pulmão fetal estando 
associada a elevadas taxas de morbilidade e mortalidade. A compreensão 
do crescimento do pulmão fetal normal e anormal, tornou-se clinicamente 
relevante pelo facto de poder oferecer novas perspetivas no tratamento de 
doenças pulmonares. Independentemente dos recentes avanços no 
conhecimento do desenvolvimento pulmonar, ainda há muito que é preciso 
fazer, ser elucidado e investigado. 
O objetivo principal desta dissertação de doutoramento foi investigar 
novos reguladores fisiológicos de crescimento do pulmão fetal, a fim de 
encontrar uma terapia pré-natal para reverter a hipoplasia pulmonar fetal no 
contexto da Hérnia Diafragmática Congénita (HDC). Por outro lado, foi 
descoberto e estabelecido um elo de ligação entre duas vias de sinalização 
(via do ácido retinóico e fatores neuroendócrinos) já bem conhecidas e 
estudadas como sendo importantes ao longo do desenvolvimento pulmonar 
fetal. Foram utilizadas técnicas moleculares/histológicas e estudos de 
ganho-perda de função com o modelo do nitrofeno em rato e com amostras 
humanas. 
Nesta tese de doutoramento, foi demonstrado que as efrinas B1,-B2 e 
o recetor eph B4 são expressos durante todas as fases de desenvolvimento 
pulmonar fetal. Além disso, a efrina B1 e o recetor eph B4 expressaram-se 
essencialmente no mesenquima enquanto que a efrina B2 apresentou ter 
uma expressão epitelial. A administração de efrina B1 e –B2 em culturas de 
explantes pulmonares, contribuiu para aumentar a ramificação pulmonar 
fetal, embora o aumento observado não tenha significado biológico 
relevante. Outro achado interessante ao longo deste trabalho de 
Doutoramento, foi a importância dos microRNAs na fisiopatologia da HDC 
em humanos. O microRNA 10a e o microRNA 200b estão aumentados em 
pulmões humanos com HDC quando comparados com pulmões normais e a 
sua expressão está também alterada no fluido traqueal em crianças que 
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sobrevivem ou morrem à oclusão fetal da traqueia (FETO). Nos pacientes 
que sobrevivem depois do FETO, após se remover o balão da traqueia, o 
fluido traqueal apresentou uma maior expressão de miR-10a e da família do 
miR-200 quando comparados com os não sobreviventes. Por outro lado, nos 
sobreviventes, a expressão desses microRNAs aumentou significativamente 
após a remoção do balão quando comparada com a expressão observada 
no momento da inserção do balão na traqueia. Em linha com o segundo 
objetivo acima mencionado, decidimos revesitar duas vias de sinalização já 
conhecidas e aparentemente não relacionadas, e descobrir uma ligação 
entre elas, pelo facto de ambas estarem alteradas na HDC (défice de ácido 
retinóico e aumento dos fatores neuroendócrinos nomeadamente da 
bombesina e da grelina). Descobrimos que os fatores neuroendócrinos 
atuam como reguladores do crescimento pulmonar, sensibilizando os 
pulmões para a ação do ácido retinóico através do aumento da expressão 
dos seus recetores (RAR α e RAR γ). 
Para concluir, nesta tese, mostramos que as efrinas parecem ser fortes 
candidatos para atuar como morfogéneos ou como fatores importantes na 
regulação vascular ao invés de serem um mecanismo importante de 
regulação do crescimento pulmonar. Por outro lado, descobrimos que os 
microRNAs são uma ferramenta importante que poderá vir a ser utilizada 
como um biomarcador de prognóstico em crianças com HDC. 
Adicionalmente, estabelecemos uma nova ligação fisiológica mostrando que 
os fatores neuroendócrinos e a via de sinalização do ácido retinóico 
interagem entre elas durante a regulação do crescimento fetal pulmonar. 
Com este trabalho, hipotetizámos novas abordagens sobre o 
desenvolvimento/regulação do pulmão fetal normal e anormal, descobrindo-
se novos mecanismos para continuar a explorar como potenciais alvos 
terapêuticos para o tratamento da HDC. 
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MKKKs: MAPK kinases kinases 
MKKs: MAPK kinases 
MRI: magnetic resonance imaging  
NEB: neuroepithelial bodies 
PDGF: platelet-derived growth factors 
PDGFR: platelet-derived growth factor receptor 
PI3K / Akt: protein kinase B 
PNECs: pulmonary neuroendocrine cells 
PPROM: preterm premature rupture of membranes 
PTC: patched receptor 
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RISC: miRNA-associated RNA-induced silencing complex  
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1. NORMAL PULMONARY DEVELOPMENT  
 
Lung is a vital organ in all species including human. Before birth, 
placenta is responsible for gas exchange so respiratory problems, caused by 
abnormal lung development, become an issue in extra uterine life. Normal 
lung development is a complex process, mediated by mesenchymal-
epithelial interactions see review (Bartis D, et al., 2014). Moreover, lung 
consists of two highly branched systems, the airways and the vasculature. 
Mammalian lung development is a long process, starting during foetal life at 
3-4 weeks of gestation in humans, and in rats at 11.5 days post-conception 
(dpc), continuing in the early postnatal years. It starts with a small 
diverticulum, the laryngotracheal groove, where the proximal portion gives 
rise to the trachea and the larynx. The distal portion is involved in the 
formation of bronchial buds, which culminate with left and right lobar 
branches from the main bronchial tree see review (Herriges M & Morrisey 
EE, 2014). 
Bronchioles are originated from lung epithelial cells that differentiate 
from the endoderm to give rise to the epithelial tube surrounded by branching 
mesenchymal cells. Anatomically, human lungs present three lobs in the right 
lung and two in the left whereas mice and rat lungs present four lobes in the 
right lung and a single lobe in the left lung. Lung development has been 
divided into six stages in all mammalian species: embryonic, 
pseudoglandular, canalicular, saccular, alveolar and vascular maturation see 
review (Correia-Pinto J, et al., 2010)(figure 1).  
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Figure 1. Overview of lung development: different phases of the developing lung in human 
and mouse, before and after birth. Adapted from (Kimura J & Deutsch GH, 2007).  
 
The embryonic stage occurs between weeks 4 and 8 of human’s 
gestation (9.5 to 12.5 in rat) and is mainly characterized by specification, 
budding of the lungs and tracheoesophageal septation. This stage 
characterizes the lung by the emergence of a ventral diverticulum of the 
foregut endoderm, separating from the oesophagus and elongating caudally. 
Sex determining region Y-box 2 (SOX 2) expression marks the proximal 
endoderm progenitor lineage. The expression of the tyroid transcription factor 
(TTF1, Nkx2.1) occurs mediated by Wnt signalling pathway and constitutes 
the first evidence of the respiratory system specification in the anterior 
foregut endoderm. A correct orchestration between SOX2, forkhead box 2 
(FOXA2), binding transcription factor (GATA 4), GATA 6 in the endoderm 
and in the mesenchyme is required to establish normal lung growth. The left 
and right lobar branches of the bronchial tree are established as well as left 
and right asymmetry where FGFs and sonic hedgehog (Shh) have a crucial 
role. For instances, inhibition of Shh is associated with abnormal lung 
development. Moreover they are also important in later phases of lung 
differentiation.  
The pseudoglandular stage occurs between weeks 8 and 16 of 
gestation in humans (12.5 to 16.5 dpc in rat). It is mainly characterized by 
airway branching. The mature conducting airway appears as a result of the 
progressive dichotomous branching as each branch bifurcates repeatedly. 
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The epithelial cells differentiate in a centrifugal manner and before 10 weeks 
after conception, the presence of cartilage can already be found around the 
main bronchi. Branching morphogenesis is regulated by several growth 
factors, receptors and signalling molecules that act as inductive signals 
mediating epithelial-mesenchymal interactions. Those interactions are crucial 
for normal lung development in early and later stages of lung growth, 
although their role during later stages of lung development is still unclear. For 
instances, FGF-10 and bone morphogenetic protein 4 (BMP4) are 
fundamental in specifying branching initiation sites and outgrowth (Weaver 
M, et al., 2000). Sprouty (SPRY) and Noggin antagonize FGF and BMP 
signalling leading to limitation of branching specificity locations. Epidermal 
growth factor (EGF), Shh and Wnt are also responsible for branching 
regulation. FGF10 is high and Shh is low (locally suppressed by patched 
receptor – PTC) where a branch is supposed to occur; so Shh, FGF10 and 
mSPRY2 may determine FGF signal and are responsible for bud outgrowth 
rate at a given point and hence interbranch length (Roth-Kleiner M & Post M, 
2003; Warburton D, et al., 2005). In contrast, branching stops when FGF10 
induces the dynamic expression of mSPRY2. mSPRY2 is synthetized at the 
most distal tip until it reaches maximum expression, inhibiting FGF10 
expression.  
The canalicular stage, occurs between 16 and 26 weeks of gestation in 
humans (16.5 to 17.5 dpc in rat) overlapping with the end of pseudoglandular 
stage. This stage is defined by the proximal-distal cell type specification and 
capillarization contributing to the beginning of blood-air interface. The 
pulmonary epithelium starts to differentiate into surfactant producers (type II 
cells) and type I cells (cells of thinned air-blood barrier). The most important 
transcription factors involved in this stage of lung development are: 
mammalian achaete-scute homologue 1 (Mash-1) and SOX 2 that are crucial 
for the pulmonary neuroendocrine cells and SOX 2, TTF 1, FOXA 2 and 
GATA 6 for the epithelial cells. In this stage the terminal bronchioles start 
dividing into respiratory bronchioles and alveolar ducts starting the gas-
exchange region. 
The saccular stage starts on week 26 and finishes on week 36 of 
gestation in humans (17.5 dpc to postnatal day 5 in rats). In this stage, lung 
Chapter I General Introduction 
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parenchyma increases by dichotomous branching of the terminal generations 
of the airway tree. Moreover the lung becomes prepared for the transition to 
air breathing with pulmonary surfactant production (4 different types of 
surfactants) by alveolar type 2 cells. The interstitium becomes thinner as a 
result of apoptosis and mesenchymal cells continue to differentiate. The first 
primitive alveoli start emerging and the capillaries grow into the mesenchyme 
surrounding the primary alveoli, forming two complex branching systems: 
airways and vasculature. In this stage the lack of amniotic fluid is associated 
with abnormal lung development and lung hypoplasia.  
The alveolar stage starts at gestation week 36 and continue through 
early childhood. Alveoli in humans can be formed until at least 2 years of 
post-natal life. In rats this stage starts in the first week after birth, and 
culminate in the first month of life. The alveoli develop from the terminal 
endings of the alveolar sac and with time, their diameter increases, as well 
as the number of terminal saccules, alveolar ducts and alveoli (Roth-Kleiner 
M & Post M, 2003). Alveologenesis consist of gas-exchange capacity 
maturation and airway wall secondary crest septation (originate alveoli) and 
elongation. Furthermore, alveologenesis increase gas-exchange surface 
area. In this stage, platelet-derived growth factor-A (PDGF-A) and its 
receptor (PDGFR-α) are one of the leading factors responsible for controlling 
alveolarization. Regarding human lung parenchyma, it changes between a 
new-born and an adult lung because this stage continues to occur after birth. 
In contrast, the number of airways generations and branching pattern are 
already established at birth.    
Vascular maturation is a postnatal stage occurring essentially during 
the first 2 to 3 years of life in humans. In this stage, capillary remodelling 
occurs and the thick capillary bilayer gives rise to a thin capillary monolayer 
(ephrins action), improving gas-exchange capacity and increasing gas-
exchange surface area.  
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2. REGULATION OF FOETAL GROWTH OF HYPOPLASTIC LUNGS 
   
Normal lung development is regulated by genetic factors; mechanical 
stimuli namely intra-thoracic compression, foetal breathing movements and 
chemical factors such as calcium concentration and relative hypoxia see 
review (Herriges M & Morrisey EE, 2014; Varner VD & Nelson CM, 2014).  
Herein the most important factors/peptides/signalling pathways studied 
in hypoplastic lungs are summarized. All the basal levels are presented and 
compared between normal and CDH lungs.  
 
Fibroblast Growth Factors 
FGFs are involved in several processes such as cell proliferation, 
differentiation and migration during organogenesis (Itoh N & Ornitz DM, 
2011). Concerning the embryonic lung, FGFs are crucial for the regulatory 
networks between epithelium and mesenchyme (Warburton D, et al., 2000). 
There are some in vitro and in vivo studies with FGFs. FGF18, FGF10, FGF7 
and fibroblast growth factor receptor-like 1(FGFRL1) show decreased 
expression in hypoplastic lungs late on gestation when compared to normal 
rat lungs (Teramoto H, et al., 2003; Dingemann J, et al., 2011; Takahashi H, 
et al., 2013). In contrast, fibroblast growth factor receptor 2 (FGFR2) and 
FGFR3 are increased in hypoplastic lungs, and when FGF10 is administered 
to lung explants, it promotes lung growth and branching (Acosta JM, et al., 
2001; Friedmacher F, et al., 2012). Moreover deficient mice for FGF10 
present lung agenesis and in normal fetal rats, in vivo localized induced 
overexpression of FGF10 induces cystic lung malformations (Ohuchi H, et 
al., 2000; Henriques-Coelho T, et al., 2007; Gonzaga S, et al., 2008). 
 
Epidermal Growth Factor and Transforming Growth Factors 
 EGF and TGFα are members of EGF family binding and activating the 
same EGF receptor (EGF-R). Their mRNA expression and immunoreactivity 
are higher during early foetal life in the bronchiolar epithelium and EGF 
proteins and EGF-R are expressed in the lung epithelium (Guarino N, et al., 
2004). 
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Regarding EGF and TGF roles, it is described that EGF and TGFβ1 
promote normal branching pattern and differentiation in the murine model 
after tracheal transection, and are involved in the regulation of normal lung 
development (Chinoy MR, et al., 1998). In CDH human lungs and in 
bronchopulmonary dysplasia (BPD), EGF and TGFα expression is increased 
in the bronchiolar epithelium and in the proximal airways (Guarino N, et al., 
2004; Le Cras TD, et al., 2004). Regarding TGFβ1 it is overexpressed on 
CDH rat lungs (Xu C, et al., 2009). Moreover, in vivo maternal treatment with 
EGF promotes lung branching and maturation, increasing lung to body 
weight ratio in nitrofen CDH rat lungs (Li J, et al., 2004). Additionally, EGFR 
null mutation leads to 50% branching reduction and to a lethal phenotype 
(Ma L, et al., 2009). 
 
Bone Morphogenetic Proteins 
BMPs are implicated in regulating lung specification, branching and 
patterning. The BMP family comprise a branch of the TGFβ superfamily 
playing a key role in development and is expressed during embryonic lung 
development. BMP4 is expressed in pulmonary epithelium, with higher 
expression in the tips and adjacent mesenchyme. Moreover BMP4 
expression is decreased in CDH rat lungs late in gestation when compared to 
normal lungs (Makanga M, et al., 2013). Misexpression of BMP4 in 
transgenic mice resulted in smaller lungs and clearly dilated terminal sacs. 
On the other hand, overexpression of BMP4 induced recover of lung 
hypoplasia promoting lung branching (Warburton D, et al., 2000). BMP4 
knockouts triggered embryonic lethality.  
 
Wingless 
Wnt is expressed during lung development, playing a key role in lung 
morphogenesis. Its expression remains unclear especially considering early 
phases of lung growth, however Wnt gene products are involved in epithelial 
to mesenchymal interactions during lung development (Takayasu H, et al., 
2010). There are some published data regarding Wnt ligands and CDH. 
Wnt2 is decreased in CDH rat lungs in the pseudoglandular stage when 
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compared to normal lungs. In opposite, Wnt5a is increased on CDH rat lungs 
late in gestation (Doi T & Puri P, 2009; Takayasu H, et al., 2010). Wnt7b 
inhibition decreased airway branching causing pulmonary hypoplasia and 
reducing lung smooth muscle (Rajagopal J, et al., 2008). Indeed, Wnt5a 
knockouts present delayed lung maturation and respiratory failure, and 
Wnt7b null mice presents hypoplastic lungs and prenatal lethality, which 
suggests their strong association with lung development.  
 
Sonic hedgehog 
Shh is a secreted glycoprotein with several patterning roles in the 
developing embryo. Looking to Shh expression in rat lungs, its expression is 
detected in the airway epithelial cells and decreased after 18.5 dpc. Shh is 
crucial for branching morphogenesis regulation because inhibits FGF 10 
expression to initiate and maintain lung branching. It is well known that Shh 
null mutants present lung hypoplasia. Shh expression is locally supressed at 
branch tips by the induction of its PTC receptor and hedgehog interacting 
protein (HIP). Consequently, the activation of PTC induces glioblastoma 
(GLI) transcription factors (Gli 1, Gli 2, and Gli 3). Moreover, CDH rat lungs 
present a decreased expression of Shh late in gestation when compared to 
normal foetal lungs (Unger S, et al., 2003).  
 
Angiotensin 
Little was known about lung development and Angiotensin. 
Angiotensinogen is expressed in epithelial, endothelial and vascular smooth 
muscle cells. Recent data showed a rat study where Angiotensin II (AngII) 
promotes in vitro lung branching mediated by type 1 angiotensin receptor 
(AT1). In foetal lung explant cultures, administration of AngII and type 2 
angiotensin receptor (AT2) agonist promotes lung branching whereas AT1 
agonist inhibits lung growth. Moreover, when AT2 agonist is administrated in 
vivo to pregnant dams, CDH new-borns present improved lung function and 
the survival rate increases (Nogueira-Silva C, et al., 2012b).   
 
Table 1 presents a summary of the molecular alterations observed in 
CDH foetal lungs. Moreover, in vitro and in vivo studies are also summarized. 
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KO – Knockout; PH – Pulmonary hypoplasia; NB – Normal branching; NA – Not available; CTR – Control; ↑ - Increased; ↓ - Decreased; = - Equal 
In vivo 
(administration) 
& 
Knockouts (KO) 
In vitro 
(administration) 
Basal levels 
 
Key molecular players 
FGF10  
= cystic lung 
anomalies CTR 
FGF10  
↑ LB CTR 
FGFR2↑ 
FGFR3↑ 
FGF18↓ 
FGF10↓ 
FGF7↓ 
FGFRL1↓  
FGF 
EGF  
↑ Lung maturation 
↑ LB CTR 
TGF β3 KO 
=Embryonic 
Lethality 
EGF 
↑ LB CTR 
TGF β1 
↓ LB CTR 
TGF β2 
↓ LB CTR 
 
 
EGF↑   
TGFα↑  
TGFβ1↑  
EGF & 
TGFs 
BMP4 KO 
=Embryonic 
Lethality 
NA 
BMP4↓ 
BMPR2↓ 
BMP7↓  
BMP 
Wnt5a KO 
=Respiratory Failure 
Wnt7b KO 
=Hypoplastic lungs 
Wnt7b inhibition= 
PH CTR 
Wnt2 ↓ 
Wnt5a ↑ 
Wnt 
Shh KO 
=Hypoplastic 
lungs 
NA 
↓ 
Shh 
AT2 ↓ 
↑ LB CTR 
NA 
AngII 
↓ PH 
 
↑ LB CTR 
↑ 
Ghrelin 
↓ PH 
NA 
↑ 
Bomb 
↓ 
RARα/β KO 
=PH 
↑ LB CTR 
↑ LB 
↓ 
RA 
Table 1. Molecular alterations in CDH foetal lungs – in vitro and in vivo studies. 
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3. EPHRINS 
 
There is a strong correlation between ephrins and its receptors with 
cardiovascular development, angiogenesis, cell migration, tissue border 
maintenance and vascular remodelling. Ephrins expression can distinguish 
between arteries, when ephrin B2 is expressed, and veins, when ephrin B4 
receptor (eph B4) is expressed, and for this reason are considered as arterial 
and venous markers, respectively (Coultas L, et al., 2005). Interestingly, 
ephrins and its receptors expression, appear before the circulatory system is 
defined, and are not restricted to arterial or vein endothelial cells. Moreover 
in lung, ephrins expression also appears in mural cells. Published data have 
shown that mice lacking either ephrin B2 or eph B4 die at 10.5 dpc. In fact, 
defects in vascular patterning in the yolk sac and within the embryo are 
displayed. Moreover, when ephrin B2 is downregulated, ephrin B2 treatment 
preserves alveolar and lung vascular growth. Ephrin B1, B2 and eph B4 
knockout mice die early in gestation and display angiogenesis impairment 
(Gerety SS, et al., 1999; Adams RH, et al., 2001; Davy A, et al., 2004).   
Eph receptors and ephrins form the largest group of the receptor 
tyrosine kinase (RTK) family and mediate numerous developmental 
processes in multiple organisms. Ephrins are transmembrane proteins that 
communicate between external stimulus and the interior of the cell controlling 
several cell processes (Bai J, et al., 2014). Indeed, ephrins are divided into 
two sub-groups: eph A and eph B, based on their ligand binding affinity and 
structure of the extracellular domain.  
There are nine eph A receptors in human genome, which connect five 
ephrins-A and six eph B receptors, and that bind three ephrins-B ligands see 
review (Park I & Lee HS, 2015). Besides, upon ephrin ligand and eph 
receptor (cell surface proteins) binding, bidirectional signalling occurs.  
Eph receptors and ephrins signalling is involved in several 
developmental processes namely cell adhesion, migration, chemo-repulsion, 
tissue morphogenesis, cytoskeleton dynamics, cell positioning, axon 
guidance, patterning, segmentation and vascular remodelling. All of these 
processes contribute to the formation of different tissues and organs. In this 
sense, they exert a central role in embryonic development, controlling cell 
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proliferation and death, cell adhesion, attraction and repulsion and cellular 
shape. On the other hand, in adulthood, they regulate remodelling of 
synapses, bone remodelling, epithelial differentiation and integrity, immune 
function, stem cell self-renewal and insulin secretion see review (Genander 
M & Frisen J, 2010). In injury conditions, eph receptors and ephrins are 
altered. For instance considering injuries in central nervous systems, ephrins 
and eph receptors are up-regulated and regarding skeletal malformations, 
they are down-regulated. Moreover eph receptors and ephrins can be 
expressed both in the same cells or they can have their own pattern 
depending on the tissues. 
Ephrins are present in different branching organs such as pancreas, 
mammary gland, kidney, and also the lung. In the lung, ephrin B1 only binds 
to some eph Bs in contrast to ephrins B2, which binds to all eph Bs receptors 
and eph A4 see review (Fagotto F, et al., 2014). Ephrin B2 was already 
tested in vivo and in vitro, in the adult rat model, and it promotes: lung repair, 
vascular growth, microvascular endothelial cell viability and consequently 
attenuates pulmonary hypertension (Vadivel A, et al., 2012). Recent data 
showed that ephrin B2 is expressed in alveolar type II cells and ephrins B2, -
B1 and eph B4 receptor are expressed in all gestational ages of lung 
development in rats (Bennett KM, et al., 2013). Ephrins and eph are also 
involved in lung cancer, being up or downregulated. For instance, ephrin A1 
overexpression is strongly associated with metastasis, tumour progression 
and bad prognosis and ephrin B3 is involved in non-small cell lung cancers 
(Stahl S, et al., 2013; Ieguchi K, et al., 2014). 
 
 
3.1 INTRACELLULAR SIGNALLING PATHWAYS 
 
Mitogen-activated protein kinases (MAPKs) constitute key downstream 
targets of FGF signalling pathway in numerous cell types. MAP kinases are 
divided into three major families: extracellular signal-regulated kinases-1 and 
-2 (ERK-1/2), c-Jun NH2-terminal kinases (JNK) and p38 kinases. MAPKs 
are known to regulate cellular proliferation and migration. The mammalian 
genome contains two ERK/MAP kinase genes, Mek1 and Mek2 that activate 
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ERK1 and ERK2. Inactivation of Mek genes in mesenchyme results in 
diverse phenotypes including lung hypoplasia. Interestingly, Mek gene 
mutation in respiratory epithelium leads to lung agenesis. ERK1 and 2 are 
typically activated by FGFs and are important for normal lung development 
(Liu Y, et al., 2004). Moreover, their role in lung development is based on the 
effects of RTK activation including hepatocyte growth factor (HGF), PDGF, 
EGF, FGF, insulin-like growth factor (IGF) and G protein activation see 
review (Ciccarelli A & Giustetto M, 2014). Thus, the ERK/MAPK pathway is 
crucial for the establishment of mesenchymal and epithelial signals required 
for respiratory tract development. On the other hand, JNK and p38 are 
involved in stress responses and apoptosis. p38/MAPK is activated through a 
cascade of kinases defined as MAPK kinases kinases (MKKKs) and MAPK 
kinases (MKKs) and is involved in controlling branching morphogenesis (Liu 
Y, et al., 2008).   
Another important signalling cascade concerning lung growth and 
development, cell proliferation and migration, is protein kinase B (PI3K / Akt). 
PI3K / AKT is an intracellular signalling pathway regulating cell cycle that 
communicates extracellular mitogenic signals to the nuclear transcriptional 
machinery (Vivanco I & Sawyers CL, 2002). AKT kinase family has three 
isoforms (AKT1, AKT2 and AKT3) and each one of them have different roles 
and functions with overlapping expression, sharing high homology see 
review (Hers I, et al., 2011). AKT1 and AKT2 are involved in different cancer 
types and have different roles. There is published data showing that AKT 
isoforms are important in pulmonary vasculature. Indeed, AKT1 is 
responsible for pulmonary vascular remodelling. AKT1 knockouts mice have 
attenuated microvascular permeability and oedema, and are protected 
against hypoxia induced pulmonary hypertension (HPH).  
Another important signalling pathway involved in lung growth regulation 
is signal transducer and activator of transcription 3 (STAT3). STAT family 
members are phosphorylated by the receptor-associated kinases and then 
they form homo or heterodimers that translocate to cell nucleus, acting as 
transcription activators mediating intracellular signalling pathways. There is 
strong evidence that STAT3 is changed in cancer. 
Regarding the signalling pathways described above, all of them can be 
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involved in foetal lung development. There are several articles showing that 
these signalling pathways can be altered in CDH conditions, or after in vitro 
administration of growth factors, proteins, or molecules that interfere with 
branching morphogenesis (Piairo P, et al., 2011; Nogueira-Silva C, et al., 
2012a; Nogueira-Silva C, et al., 2013).  
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4. NEUROENDOCRINE FACTORS 
 
Pulmonary neuroendocrine cells (PNECs) are present in the airway 
epithelium of human and animal lungs, playing a role in the regulation of lung 
growth and maturation. Moreover, PNECs are involved in pulmonary 
development and also in the regulation of pulmonary vascular tone. During 
the last decade, several studies showed that PNECs, in the early stages of 
lung development, are modulators of foetal lung growth and differentiation. 
Interestingly, at the time of birth, they act as airway O2 sensors involved 
mainly in neonatal adaptation. Postnatally, PNECs / neuroepithelial bodies 
(NEB) are important in airway epithelial regeneration and lung 
carcinogenesis providing a lung stem cell niche. PNECs constitute the first 
cell type to differentiate in lung airway epithelium see review (Cutz E, et al., 
2007). 
Bombesin and ghrelin are neuroendocrine peptides and have key roles 
in lung development and maturation during intrauterine life until postnatal 
period. Bombesin is produced by PNECs and ghrelin is mainly synthesized in 
the endocrine A-like cells of oxyntic mucosa of the stomach. Regarding 
bombesin, its expression is maximal during the pseudoglandular and 
canalicular stages. Moreover, in vitro or in vivo blocking of bombesin retards 
lung epithelial development. Thus, bombesin seem to play a physiological 
role in the induction of lung morphogenesis. In CDH rat lungs, bombesin is 
increased when compared to normal lungs and promotes lung branching 
(Warburton D, et al., 2000; Cutz E, et al., 2007).  
A recent study showed that in vivo administration of bombesin to 
nitrofen pregnant rats, promotes lung development and rescues lung 
hypoplasia in CDH embryos (Sakai K, et al., 2014). 
Concerning ghrelin expression, ghrelin presents higher expression in 
the airway epithelium during the pseudoglandular stage, suggesting its role in 
branching morphogenesis (Volante M, et al., 2002; Santos M, et al., 2006; 
Cutz E, et al., 2007). Moreover ghrelin expression has been reported in other 
branching organs such as pancreas, kidney, mammary gland and placenta. 
Published data has shown that maternal ghrelin administration 
attenuates pulmonary hypoplasia in rat foetuses with CDH, and that ghrelin is 
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overexpressed in human and rat hypoplastic lungs. Additionally in vitro 
ghrelin administration to foetal lung explants increases lung branching in 
normal lungs (Santos M, et al., 2006; Nunes S, et al., 2008). 
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5. RETINOIC ACID 
 
Retinoids (retinoic acid and related signalling molecules) play an 
essential role in several aspects including pregnancy maintenance, foetal 
and perinatal growth, embryogenesis and organogenesis, namely in lung 
development (its important in all stages of lung development). In adulthood, 
they regulate immunity, reproduction, vision and are crucial for proper 
functioning of lung, liver and neural system. Moreover, retinoic acid (RA) 
deficit, the biologically active form of vitamin A, is strongly associated with 
diaphragmatic defects at birth, hypoplastic lungs, pulmonary agenesis and 
tracheoesophageal septum development. 
Indeed, Vitamin A administration in rats’ diet during pregnancy and in 
vivo administration of RA to pregnant rat dams has been shown to revert 
lung hypoplasia in embryos and decreases the incidence of diaphragmatic 
defects (Thebaud B, et al., 1999). Furthermore, exogenous administration of 
RA into nitrofen lung explant cultures, rescues abnormal lung branching 
(Baptista MJ, et al., 2005; Montedonico S, et al., 2006; Pederiva F, et al., 
2012). However, high concentrations of RA are associated with adverse 
effects, namely teratogenicity and consequently its extremely important to 
have a RA balanced diet (Hunt JR, 1996). Recent studies suggest that RA 
signalling pathway is disturbed in the nitrofen model of CDH justified by the 
fact that nitrofen inhibits RALDH 2 (enzyme responsible for catalysing the 
final step in RA production). Indeed a genetically engineered modified mice 
was created to test this hypothesis see review (Montedonico S, et al., 2008). 
In normal lung development, RALDH 2 expression, is downregulated in 
budding regions and its high in proximal regions of the lobes. There is a 
proximal-distal gradient pattern of RA expression. In this sense, the 
morphogenesis and shape of an organ can be determined by a concentration 
gradient of a molecule that gives cells polarity.  For instances in the limb, 
there are two well described gradients of signalling (antero-poterior and 
proximal-distal) and RA is involved in proximal-distal pattern formation 
(Towers M, et al., 2012). Vertebrate limbs develop in a temporal proximal-
distal sequence, where proximal regions are specified and generated earlier 
than distal ones. After limb bud formation, RA synthesis and signalling is 
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restricted to the proximal limb by FGF activity. Considering lung it is 
described that RA blocks formation of the distal lung and induces a proximal-
like phenotype in lung epithelial tubules. Pattern formation is a crucial 
element of lung development since the epithelial phenotypes differ between 
proximal and distal structures (Cardoso WV, 1995). In vitro experiments were 
done and FGF10 and Shh are downregulated within the distal buds following 
exogenous RA administration (inhibitory effect of RA signalling upon 
branching morphogenesis). 
In the liver, retinyl esters are metabolized into retinol. Retinol binds to 
retinol-binding protein (RBP), and RBP binds to cell surface receptors and is 
transported in the cytoplasm bound to cellular retinal-binding proteins 
(CRBP), where it is converted to retinal by retinol dehydrogenase (RALDH) 
(Figure 2). After RA synthesis in the cell, it enters in the nucleus. There are 
two classes of retinoic receptors: retinoic acid receptors (RAR) and retinoic X 
receptors (RXR) and each one of them have three isoforms α, β, γ (Hind M & 
Maden M, 2004). RARs can form homodimers with RAR members or 
heterodimers with members of the RXR subfamily.  
It is described that overexpression of ALDH1A2 (aldehyde 
dehydrogenase) is not a primary event, but it is a consequence of CDH-
induced lung injury (Coste K, et al., 2015). Moreover, double knockouts of 
RAR α and RAR β display lung hypoplasia and failure in the oesophagus 
trachea separation and in vivo administration of RAR antagonist (BMS493) 
leads to mice embryos without evidence of lung buds see review (Mollard R, 
et al., 2000). When RA is absent, FGF10 decreases and TGF β increases, 
reducing lung branching. RA is a major regulator of Wnt signalling and TGF β 
pathway, controlling FGF10 expression since early in gestation (Chen F, et 
al., 2010). RAR α is responsible for the correct number of alveoli to develop 
after perinatal period in mice, whereas RAR β restricts the number of alveoli 
being formed and RAR γ also regulates this process (Gallot D, et al., 2005; 
Gudas LJ, 2012). Concerning branching, RAR α downregulation is required 
for sacculation in the developing lung. Among RA receptors, only signalling 
from RAR β and RAR γ is involved in branching morphogenesis. RAR β 
transcripts are expressed within the proximal airways of the pseudoglandular 
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lung. These are downregulated distally where there is increased branching 
activity. In this sense, endogenous RA signalling acts via RAR β to stabilize 
tubule formation by limiting the number of buds that emerge during branching 
morphogenesis. RAR γ displays a restricted pattern of expression in the 
developing lung, being expressed within the distal bud epithelium. RAR γ is 
not involved in transducing the RA signal, which inhibits distal lung bud 
formation in contrast with RAR β (Mollard R, et al., 2000). 
 
 
Figure 2. Schematic overview of retinoic acid signalling pathway. TTR: transthyretin; 
ROLDH: retinol-dehydrogenase; CRBP: cellular retinol-binding proteins; RALDH: retinal 
dehydrogenase; RAR: retinoic acid receptors; RXR: retinoid x receptors; RBP:  retinol-
binding protein (Montedonico S, et al., 2008). 
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6. MICRORNAS 
 
MicroRNAs are small non-coding RNAs that regulate gene expression, 
by targeting transcription or inhibiting translation. MicroRNAs have 
approximately 22 nucleotides in length and are highly conserved among 
animals, plants and other organisms, suggesting that microRNAs represent a 
highly conserved and important regulatory mechanism see review 
(Aghanoori MR, et al., 2014). In the nucleus, primary (pri)-microRNA is 
transcribed by RNA polymerase II. RNase III enzyme Drosha processes pri-
microRNA into precursor microRNA (pre-microRNA). Pre-miRNA is 
transported into the cytoplasm through exportin-5, and is digested by RNase 
III endonuclease, Dicer, to double-stranded microRNA molecules. Dicer 
cleaves the pre-microRNA and generates a mature microRNA. The mature 
microRNA is then separated into two single-stranded molecules: the 
antisense strand participates in the RNA-induced silencing complex (RISC) 
and is recruited by Argonaute (Ago) proteins, while the sense strand is 
targeted for degradation. Inside RISC, microRNA can bind to the 3’-
untranslated region (3’UTR), or in some cases to the 5’UTR of target mRNA, 
to repress translation or induce cleavage (Figure 3). Ago 1 and Ago 2 
constitute the two most highly expressed Ago proteins in mammals see 
review (Comer BS, et al., 2015).   
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Figure 3. MicroRNA biogenesis and mechanisms of gene silencing (Comer BS, et al., 
2015). 
 
The first microRNA reported was Lin-4 in 1993 and Let-7 was the 
second discovered in 2000. 33% of the human genome is regulated by 
microRNAs (Lee RC, et al., 1993; Sessa R & Hata A, 2013).  
Down-regulation or up-regulation of microRNAs can be associated with 
the origin of several diseases, such as cancer, respiratory and cardiac 
problems. For instance, recently published data has shown that miR-205 
deregulation and miR-200 family downregulation are associated with breast 
cancer (Gregory PA, et al., 2008). MicroRNAs are linked to cell physiology, 
development, differentiation, proliferation, metastasis and apoptosis. 
Currently, microRNAs have emerged as a future strategy to develop more 
effective therapies, improving drug efficiency, or to be used as potential tools 
in the diagnostic and prognostic of diseases. MicroRNAs are stable and easy 
to manipulate because they are small and can even cross the placenta. 
Considering normal developed tissues, deregulation of microRNAs is well 
tolerated, although in pathological conditions, that does not happen. 
Regarding oligonucleotides, locked nucleic acid (LNA), they present a 
modification in the ribose ring, improving nuclease resistant and conferring a 
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high affinity for complementary sequence, being more stable and promisor 
when used in in vivo treatments see review (Sessa R & Hata A, 2013). 
 
 
6. 1 MICRORNAS IN LUNG 
 
Regarding lung development and epigenetics, DNA methylation and 
histone modifications are the best-studied epigenetic mechanisms, however 
microRNAs have also recently emerged as an important class of members of 
the epigenetic machinery see review (Vasilatou D, et al., 2013). MicroRNAs 
are present as multifunctional molecules and several studies using cells and 
animal trials have shown and characterized their expression.  
The first evidence correlating lung development with microRNAs was 
observed in Dicer knockout mice and conditional cells, in which branching 
was abrogated in embryonic lungs or a defective airway branching in the 
cells was observed respectively. Moreover, concerning the embryonic stage 
(E 11.5), Ago 1 and Ago 2 are vastly expressed in epithelial and 
mesenchymal regions, showing the importance of microRNA regulation in 
lung remodelling and maturation see review (Johar D, et al., 2014). 
Concerning the pseudoglandular stage, miR-17-92 cluster is important in 
controlling differentiation and proliferation of lung progenitor cells. 
Furthermore, deletion of miR-17-92 cluster leads to hypoplastic lungs, 
ventricular septal defects and postnatal death of all mice (Bienertova-Vasku 
J, et al., 2014). By contrast overexpression of miR-17-92 cluster in the lung 
epithelium induces hyperproliferation and inhibits differentiation of proximal 
and distal epithelial progenitor cells. 
Concerning asthma, knockdown studies have shown that microRNAs 
are involved in the aetiology of the disease and can be a potential 
therapeutic target for the disease as well (Wang Y, et al., 2007; Booton R & 
Lindsay MA, 2014). 
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6. 2 MICRORNA 200 AND MICRORNA 10 FAMILIES 
 
MiR 200 family is composed by two clusters: miR-200a, miR-200b and 
miR-429 share a common transcription start site on chromosome 1; miR-
200c and miR-141 are transcribed as a single unit from chromosome 12 see 
review (Howe EN, et al., 2012).  
The role of miR-200 in lung development is not clear and defined, 
although miR-200b plays a crucial role in cancer invasiveness and tumour 
metastasis. MiR-200b has been associated with epithelial to mesenchymal 
transition (EMT) and mesenchymal to epithelial transition (MET). Moreover, 
the members of miR–200 family have been highlighted for its importance in 
the maintenance of the epithelial phenotype, since they inhibit EMT, by 
directly targeting and downregulating zinc finger E-box-binding homeobox 
(ZEB) 1 and ZEB2, resulting in enhanced E-cadherin expression. 
When miR-200b is up-regulated, carcinoma cells become more 
epithelial leading to MET and indeed when miR-200b is downregulated the 
cells become more mesenchymal leading to EMT (Wang G, et al., 2013; 
Diaz-Lopez A, et al., 2015).  
On the other hand, miR-200 family is altered in idiopathic pulmonary 
fibrosis (IPF) and miR-155 is up-regulated. MiR-155 regulates negatively 
TGF-β1 signalling in macrophages, silencing SMAD2 and promoting EMT, 
and miR-200b regulates one of the known target genes TGF-β / SMAD 
signalling in a complex way (Louafi F, et al., 2010).  
Regarding miR-10 family, less is known about these microRNAs and 
lung development. Two members compose miR-10 family: miR-10a and miR-
10b that differ from each other just in one base. MiR-10 family is located 
within the Hox clusters of developmental regulators and are highly conserved 
for correct animal anterior-posterior patterning. They are positioned in close 
proximity to Hox 4 paralogues playing a role in the determination of body 
plans. 
In cancer, miR-10 family expression was found to be deregulated 
however information about the role and function of miR-10 family is still 
missing.  
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MicroRNAs have been associated with two opposite roles including 
promotion and inhibition in every metastatic step processes, and miR-10b is 
known to be involved in tumour progression and metastasis. Moreover miR-
10a has an important role in cellular processes such as differentiation, 
apoptosis, cell survival, replication and senescence in embryonic 
development. Additionally miR-10 family has been associated as a key 
player in RA induced responses. In vitro studies have shown that miR-10a 
and miR-10b are overexpressed in RA treated cells. On the other hand, 
inhibition of miR-10a before RA treatment in smooth muscle cells was shown 
to abolish their differentiation. However miR-10a by itself was unable to 
conduct smooth muscle cells differentiation see review (Tehler D, et al., 
2011).  
 
 
6.3 TGF BETA 
 
TGFβ superfamily is divided in three subfamilies: activin, TGFβ and 
BMP. There are three TFGβ isoforms in mammals: TGFβ1, 2 and 3. TGFβ is 
strongly associated with lung development and all isoforms have been found 
in murine embryonic lungs see review (Warburton D, et al., 2005). Moreover, 
TGFβ is involved in embryonic development, organogenesis, tissue 
homeostasis and also in cell-extracellular matrix (ECM) interactions.  
Published data has shown that microRNAs interfere in TFGβ pathway 
at multiple levels, and that TGFβ increases the maturation of microRNAs. 
SMAD constitutes a downstream target of TGFβ signalling pathway see 
review (Sivadas VP & Kannan S, 2014). 
Regarding TGFβ1, it is expressed in the mesenchyme underlying distal 
epithelial branching points, and is responsible for structural remodelling, 
epithelial changes, immunosuppression processes of inflammatory airway 
diseases and repair of fibrosis formation (Lee CM, et al., 2014). Moreover, 
mice lacking TGFβ1 die at few weeks after birth with multiorgan autoimmune 
inflammatory diseases.  
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TGFβ2 is localized in distal epithelium, playing a key role in branching 
morphogenesis. TGFβ2 knockout mice die in utero with severe cardiac 
malformations (Warburton D, et al., 2005).  
TGFβ3 is expressed in proximal mesenchyme and mesothelium, and is 
important in regulating alveolar epithelial cell proliferation during injuries. 
TGFβ3 mutants die after birth, presenting lung dysplasia and cleft palate. 
Indeed a well regulated expression and pattern of all TGFβ is required 
for normal lung development, avoiding lung inflammation and lung diseases. 
Recently published data has shown that overexpression of TGFβ1 leads to 
hypoplastic phenotypes and exogenous administration of TGFβ1 to 
embryonic mouse lungs resulted in blocking of lung branching. In contrast, 
inhibition of TGFβ type II receptor stimulated lung branching (Bragg AD, et 
al., 2001).   
Additionally, TGFβ family is very important in the regulation of 
alveologenesis and in controlling of EMT interactions that are crucial for 
normal lung development. Indeed TGF-β signalling has different effects in 
epithelial vs mesenchymal cells. Recent published data revealed that, TGFβ1 
addition to lung explant cultures induces arrested lung development, 
decreased lung differentiation and lung vasculature (Pain M, et al., 2014). 
Moreover, null mutations of TGF-βs are associated with abnormal lung 
development or post-natal lung inflammation, and TGF-β blockage inhibits 
EMT in chicken atrioventricular explants. In fact, TGF-β2 administration 
induces EMT in mouse explant cultures. 
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7. CONGENITAL DIAPHRAGMATIC HERNIA 
 
Congenital diaphragmatic hernia (CDH) is a congenital anomaly that 
does not represent a problem for babies during gestation, since they receive 
oxygen from the placenta; however, foetal lung hypoplasia, with associated 
severe persistent pulmonary hypertension, limits their survival after birth 
(Colvin J, et al., 2005; Rocha GM, et al., 2008).  
Nowadays, CDH has an incidence of 1:2.500 live births with a high rate 
of morbidity and mortality and a poorly understood aetiology (Keller RL, et 
al., 2010). CDH aetiology is unknown in more than 80% of the cases and no 
specific genetic defects or environmental factors have been associated with 
CDH. A better understanding of normal lung development will help to 
overcome lung problems, including CDH, and improve survival.  
In humans, there are four types of diaphragmatic defects: posterolateral 
or Bochdalek type, anterior Morgagni type, central hernia or septum 
transversum type and diaphragmatic eventration type. The most common 
type is the Bochdalek hernia that has an incidence of 80% and occurs 8 
times more often on the left side than on the right (due to the fact that 
diaphragm closure start by the right side) (Tibboel D & Gaag AV, 1996; van 
Loenhout RB, et al., 2009). CDH is a multifactorial disease and normally 
appears with associated anomalies such as cardiac, renal and skeletal 
malformations (Holder AM, et al., 2007). Interestingly, it was found in animal 
studies that foetal lung hypoplasia is associated with early and late 
gestational determinants (dual-hit hypothesis). Early determinants involve 
molecular disturbances and are associated predominantly with the 
pseudoglandular and canalicular stages of lung development, affecting 
branching mechanisms. Late determinants are related to mechanical factors 
(visceral compression) and affect mainly the saccular and alveolar stages 
(Keijzer R, et al., 2000). However, fetal diaphragmatic surgical repair was not 
able to revert the ominous prognosis of CDH. In this sequence, for severe 
cases of CDH with a really bad prognosis, fetoscopic endoluminal tracheal 
occlusion (FETO) appears promising in some specific and specialized 
centres. Other possibilities are prenatal hormonal therapies. In chapter 2 we 
summarized the most recent results of this strategic research line based in 
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the knowledge of regulatory pathways in lung growth for which experimental 
models are crucial. Interestingly, recent exotic prenatal therapies have 
emerged as a potential therapy for these babies which clinical impact is still 
unknown (Lemus-Varela Mde L, et al., 2014; Sakai K, et al., 2014; Makanga 
M, et al., 2015; Rhodes J, et al., 2015).  
 
 
7.1 CDH ANIMAL MODELS 
 
Animal models are very useful to study early embryonic development, 
allowing a better understanding of normal and pathological growth 
(Beurskens N, et al., 2007).  
There are three different animal models available to study CDH: 
surgical, genetic and teratogenic. 
Surgical models that mimic CDH are obtained by surgery where a 
whole in the diaphragm, of rabbits and sheeps is performed. However it does 
not mimic CDH properly because it is an artificial defect created on the 
diaphragm late on gestation and the lung is not hypoplastic. In this sense it is 
not a good model to understand and find the molecular mechanisms and 
signalling pathways that can be altered in CDH (Beurskens N, et al., 2007; 
van Loenhout RB, et al., 2009). 
Considering genetic models, published data with knockout mice 
showed that the genes that are affected correspond to regions commonly 
deleted or duplicated in CDH in humans. Moreover, CDH is strongly 
associated with RA signalling pathway and double null mutant mice lacking 
RARα and RARβ have offspring with CDH. Furthermore, RARα and RARβ 
are expressed in the developing diaphragm (Mendelsohn C, et al., 1994; 
Lohnes D, et al., 1995; Greer JJ, et al., 2003). Other genetic alterations that 
can lead to CDH are homozygote mice for Fog2 (premature stop codon), 
heterozygous Gata4 knockout mice, changes and deletions of COUP-TFII 
and retinol-binding protein (RBP)-1 and RBP-2 (Beurskens N, et al., 2007). 
Regarding teratogenic models, CDH can be induced with bisdiamine 
(most potent inhibitor of retinal dehydrogenase 2-RALDH 2), biphenyl 
carboxylic acid, SB-210661 (a benzofuranyl urea derivate) and nitrofen. 
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The administration of the herbicide nitrofen (2,4-dichlorophenyl-p-
nitrophenyl ether) to pregnant rats on 9.5 dpc (100mg of nitrofen dissolved in 
1ml of olive oil by gavage), induces congenital anomalies in the offspring, 
mainly diaphragmatic defects, pulmonary hypoplasia and associated 
malformations such as cardiac problems. The nitrofen model is the most 
used and it is the one that better mimic CDH in humans. However the 
herbicide nitrofen does not induce CDH in humans (Correia-Pinto J, et al., 
2003; Beurskens N, et al., 2007; Kling DE & Schnitzer JJ, 2007; van 
Loenhout RB, et al., 2009; Clugston RD, et al., 2010). There are strong 
evidences showing that nitrofen affects RA signalling pathway, which is key 
in lung development and is also disturbed in CDH in humans. On the other 
hand, vitamin A administration to pregnant rats can reverse CDH (Mey J, et 
al., 2003; Baptista MJ, et al., 2005; Beurskens LW, et al., 2009).   
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7.2 FETO 
 
It is possible to diagnose CDH from 15 weeks gestation by ultrasound 
or magnetic resonance imaging (MRI). Additionally, liver position / herniation 
and estimated lung to head ratio (LHR) are good parameters to predict CDH 
outcomes (Figure 4). Moreover CDH associated with other congenital 
anomalies and malformations is associated with a bad prognosis outcome 
and sometimes termination of pregnancy is suggested (Dekoninck P, et al., 
2011; Delacourt C, et al., 2012; Deprest J, et al., 2014).  
 
Figure 4. Survival rates of foetuses with left-sided CDH, depending on the 
observed/expected lung head ratio (O/E LHR) and liver position. Percentages below graphic 
refer to the number in each severity group (Deprest J, et al., 2014). 
  
FETO was first proposed by Jay Wilson and his team from Boston 
(Wilson JM, et al., 1993; DiFiore JW, et al., 1994). It is recommended, in 
severe cases of CDH, without other associated anomalies, in order to 
improve the outcome of these babies. Although FETO improves lung growth, 
it is invasive, technically demanding and limited by maternal and foetal risks. 
Actually FETO consists in in utero insertion of a balloon in the trachea 
around 28 weeks of gestation, and the puncture of the balloon by ultrasound 
guidance should be done around 34 weeks. In some cases, preterm 
premature rupture of membranes (PPROM) occurs and the balloon cannot 
be removed before birth, so it needs to be done during delivery. The tracheal 
occlusion prevents lung fluid to egress, thereby inducing tissue stretch 
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leading to lung growth and maturation. FETO increases survival in severe 
cases of left-sided CDH from 24.1% to 49.1% and in right-sided from 0% to 
35.3% (Deprest J, et al., 2011; Deprest JA, et al., 2011). On the other hand, 
FETO still presents problems such as PPROM and the fact that it is a 
invasive and risky procedure. Moreover, lung maturation is still limited when 
compared to normal lungs, reinforcing the idea that FETO should only be 
done in severe cases of CDH with a really poor prognosis (Mimmi MC, et al., 
2015; Xie A, et al., 2015). 
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AIMS 
 
During the last decades, lots of efforts and advances had been done in 
order to treat and increase the quality of life of patients suffering from lung 
pathologies, namely CDH. In this sense, the main challenge of this disease is 
to reduce mortality and morbidity by trying to find new treatments for these 
patients. Improvements and sophisticated techniques such as foetal surgery, 
FETO, ECMO and intensive care before and after birth emerged although the 
morbidity rate still remains high in mild and severe cases of CDH. In order to 
find a potential treatment it is crucial to understand completely normal 
pulmonary development. The knowledge of the underlying molecular 
mechanisms and interactions involved in normal lung growth and maturation, 
will improve to the understanding of abnormal lung development. Thus the 
following aims were pursued in this PhD thesis:   
1) To investigate the role of receptors tyrosine kinases, namely ephrins 
on normal foetal lung growth; 
2) To predict surveillance of CDH patients analysing microRNAs 
present in lung and amniotic fluids before and after FETO; 
3) To study the role of neuroendocrine factors and RA during normal 
and abnormal lung development;  
4) To find new prenatal therapeutical approaches to revert foetal lung 
hypoplasia in CDH context.  
 
 
THESIS LAYOUT 
  
This PhD thesis is organized into seven different chapters. In chapter I, 
a general introduction on the subject of the thesis is presented, including 
normal lung development regulators and signalling pathways, and abnormal 
lung development (CDH pathophysiology). Chapter II, presents the first 
manuscript published accordingly to the aims of this thesis entitled “ The role 
of ephrins B1 and –B2 during foetal rat lung development”. In this study we 
investigated the expression pattern of ephrins B1, -B2 and eph B4 receptor in 
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rat foetal lung development and we explored the effects of ephrin B1 and –
B2 supplementation in rat foetal lung explant cultures regarding the potential 
effects in growth regulators signalling pathways. Chapter III, presents a 
manuscript entitled “Unique tracheal fluid microRNA signature predicts 
response to FETO in patients with congenital diaphragmatic hernia”. This 
study strongly contributed to find potential biomarkers that can be useful as 
prognostic tools for CDH babies. Chapter IV, an article entitled “ 
Neuroendocrine factors regulate retinoic acid receptors in normal and 
hypoplastic lung development” is presented, where a putative link between 
neuroendocrine factors and RA pathway was established. The overall aim of 
this dissertation was to further understand lung development in order to find 
a potential prenatal therapy for CDH patients. On Chapter V, a general 
discussion of the most important results of this PhD work is presented. On 
Chapter VI the major conclusions are presented. The last chapter is Chapter 
VII, where all the references from the thesis are presented in alphabetical 
order.
 CHAPTER II. 
EPHRINS AND FOETAL LUNG GROWTH
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Abstract 
Background/ Aims: The knowledge of the molecular network that governs fetal lung branching 
is an essential step towards the discovery of novel therapeutic targets against pulmonary 
pathologies. Lung consists of two highly branched systems: airways and vasculature. Ephrins 
and its receptors, Eph, have been implicated in cardiovascular development, angiogenesis 
and vascular remodeling. This study aims to clarify the role of these factors during lung 
morphogenesis. Methods: Ephrins-B1, -B2 and receptor EphB4 expression pattern was assessed 
in fetal rat lungs between 15.5 and 21.5 days post-conception, by immunohistochemistry. 
Fetal rat lungs were harvested at 13.5 dpc, cultured during 4 days and treated with increasing 
doses of ephrins-B1 and -B2 and the activity of key signaling pathways was assessed. Results: 
Ephrin-B1 presents mesenchymal expression, whereas ephrin-B2 and its receptor EphB4 were 
expressed by the epithelium. Both ephrins stimulated pulmonary branching. Moreover, while 
ephrin-B1 did not affect the pathways studied, ephrin-B2 supplementation decreased activity 
of JNK, ERK and STAT. This study characterizes the expression pattern of ephrins-B1, -B2 and 
EphB4 receptor throughout rat lung development. Conclusion: Our data highlight a possible 
role of ephrins as molecular stimulators of lung morphogenesis. Moreover, it supports the 
idea that classical vascular factors might play a role as airway growth promoters.
F.O. Peixoto and P. Pereira-Terra contributed equally to this manuscript.
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Introduction
Lung morphogenesis is a very complex and tightly regulated phenomenon. Transcription 
factors, extracellular matrix molecules, intercellular adhesion molecules and soluble growth ???????? ????? ????? ??????????? ??? ???????????? ???????? ??? ??? ?????? ????????????? ??????????
these molecular players act along the proximal-distal axis of the respiratory tract and ?????????????????????????????????????????????????????????????????????????????????????????????
development of the immature lung [1].
The Eph receptors and their ligands, ephrins, constitute the largest subgroup of the 
family of receptors tyrosine kinase (RTKs). This family of receptors is divided into two 
subgroups based on the similarity of their extracellular domain sequences, whereas ephrins ??????????????????????????????????????????????????????????????????????????????????????????????
subgroup [2]. Regarding ephrins-B, Eph/ephrin signaling can be bi-directional, inducing 
intracellular pathways downstream of both the Eph receptor and the ephrin ligand. The latter ?????????????????????????????????????????????????????????????????????????????????????????????
to EphB receptors, ephrins are also able to bind and activate Eph receptors from the opposite ?????????????? ??????????????????????????????????????????????????????????????????????????????
as reported for ephrin-B2, which mainly binds to EphB4 receptor [5, 6].
The roles of ephrins in cell adhesion, vascular development, cell migration and tissue-??????? ???????????? ?????????? ?? ?????????? ????? ??? ????? ?????????? ?????????????? ???? ????
In fact, ephrins expression has been described in other organs that, as the lung, develop 
through branching processes. For instance, the expression of ephrins-B1 and -B2, and EphB4 ????????????????????????????????????????????????????????? ????? ???????????????????????
mouse pancreas [8-10]. The expression of ephrin-B2 and its receptor has also been detected 
in fetal mouse kidney [11]. It is noteworthy that ephrin-B1 mutations have been found in ??????????????????????????????????????????????????????????????????????????????????????????
defects and consequently lung defects [12-16]. Moreover, another study described ephrin-B1 
gene (EFNB1) duplications in fetuses that died from CDH and concomitant pulmonary ??????????? ???? ??? ?????? ????????????? ?????? ??? ???? ?????? ?????? ?????????? ???? ??????
receptor have been widely described as arterial and venous markers, respectively, and 
implicated in the development of the vascular system during embryogenesis [5, 6, 18, 19]. ??????????? ???????????????????? ????????????????? ??????????? ??? ??????????????????? ??????
from mouse adult lung [20]. 
There is extensive evidence for a direct synergism between pulmonary vascular and 
airway development. Indeed, vascular regulatory factors play a crucial role in airway and 
alveolar morphogenic processes, and growth factors produced in the airway epithelium can 
also regulate vasculature formation [21-24]. 
Ephrins have been described as crucial for microvascular maturation mainly during 
septum maturation and capillary remodeling from double into a single capillary layer. 
They are also known to be involved in the process of alveologenesis, contributing for the 
establishment of the secondary septa and for alveolar formation [25, 26]. In fact, ephrin-B2 
has been described as a contributor to normal postnatal alveolar development as its inhibition 
leads to arrested alveolar and abrogated lung vascular growth. Moreover, in a setting where 
ephrin-B2 is downregulated, ephrin-B2 treatment preserves alveolar and lung vascular ?????????????????????? ?????????????????????????????
2
-induced arrested alveolar growth ??????????????????????????????????????????? ???????????????????????????????????????????
several defects including angiogenesis impairment. In published data with Ephrin-B2 or 
EphB4 knockout mice, stained vessels were completely absent in knockouts [28, 29]. Thus, 
ephrin-B1, ephrin-B2 and its main receptor appear as potential key players in fetal lung 
development. Nonetheless, very little is known regarding ephrins-B1 and -B2 function 
during fetal lung development. Hence, in the present work we aimed to disclose novel roles 
of such proteins in normal lung development.
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Materials and Methods
Ethics Statement????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????? ?????????????????????????????????????? ??????????????????? ???????? ????? ??????? ??? ??? ??????????? ?????? ???? ???????? ??? ?????????? ??? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????? ????????????????????? ???? ??????? ????????
animal suffering.
Experimental Design and Animal Model??????????????? ??????? ????? ??????? ??????????????? ????? ??????????? ??? ???????????? ?????? ??????
controlled conditions and fed with commercial solid food. The rats were mated and checked daily for vaginal ?????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???? ????????????????????????????????????????????????????????????? ????????? ?????? ????????????? ?????? ???? ?????????? ??????? ???? ????????????????????? ?????? ?????????????????????????????????????????????? ??????????????????????????????????????????????
Immunohistochemistry ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????®?????????????????????????????????????????????????????????????????? ????????????????????????????????????? ????????????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????? ??????????????????? ????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??? ?? ?????? ????????? ??????? ????? ??????????????? ?????? ?????????? ????????? ???????? ??????????
included omission of the primary antibody. The incubation with the corresponding secondary antibodies ?????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????? ???? ????????????????????????????? ????????????? ?????? ????????????????????? ??????? ???????????????? ???????????? ??????????? ???????? ???????????? ???????????? ??? ????????????????????? ?????????? ?????????????????????? ??????????????????? ??????? ??????? ???? ?????? ????????? ???????????????????? ????????????????????
Fetal lung explant cultures?????? ??????????? ???? ???????????? ????? ???? ?????? ????? ???????????? ??? ?? ??? ???????? ??????????
(Millipore, ??????????? ??????????? ??????? ??? ????? ???????? ????????? ???? ?? ?????? ????????? ????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???????? ?????????????????????????????????????????????????????????????? ????????????????????????????????????????????? ??? ?????????????????????????
serum (Invitrogen)? ?????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????????????????
groups (control and three doses for each protein) were all constituted by n=12 lungs. The explants were ?????????? ??????????
2
? ??????????? ????????????????????????????????????????? ??????????????????????????????????? ???? ????? ??????????????? ??????? ????????? ?????????????? ?? ??? ???
0
?? ? ?????? ??? ??? ???
4
??
96 hours) of culture, the total number of peripheral airway buds (branching), the epithelial perimeter, the ????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????? ??????? ????????????????????????????????????????????????????????????? ??????????????
as D
4
/D
0
???????????????????????????????????????????????????? ???? ???????????????????????????????????????????
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Western blot??????????????????????? ??????????? ?????? ?????? ????????????????????? ???? ?????????????????? ???????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????? ???????????????????????????????????? ?????????????????????????????????? ????? ???????????????? ???? ????? ???????????? ??? ??????????????? ?????????? ?????????? ??? ??????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???? ?????? ???????? ?????? ????????? ????? ????????????????????? ?????? ?????????? ???????????????????????????????? ????????? ??? ?????????????? ?????????? ????????? ????? ????? ?????????????????????? ??? ???? ?????????????? ??????????????? ???????? ???? ?????? ???????? ???????? ???? ????? ???? ????? ??????????? ???????? ?????????????????????????????????????????????? ??????????? ????????????????????????????????ab6046).
Blots were incubated with a secondary anti-rabbit ???????????? ??????????? ?????????? ??????? ?????
Biotechnology Inc., sc-2004??? ????????? ????????????????? ???????????????????????????? ?????????????????????????????? ????????????????????? ?????????????????????????? ????????????????? ????????????????????????????????? ????????????? ?????????????????????????????????????????????????????????????????????????
Statistical Analysis?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????
Results
Pulmonary expression pattern of ephrin-B1, ephrin-B2 and EphB4 receptor
In order to determine ephrin-B1, ephrin-B2 and its receptor EphB4 expression 
pattern during fetal lung development, immunohistochemical analysis was performed ???? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
expression is absent, as well as endothelial expression.
Remarkably, ephrin-B2 expression pattern is highly distinct from ephrin-B1 (Fig. 1B). 
Ephrin-B2 is predominantly expressed in the epithelial compartment, and it is also observed ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????
expression appears to be restricted only to epithelial cells from terminal and respiratory 
bronchioles.????????????????? ????????????? ?????????????????????????????????????????? ?????? ???????????????????????????????????????????????????????????????????????????????????????????????????????
EphB4 receptor is also weakly expressed in potentially less differentiated cells surrounding 
the epithelium. This expression seems to diminish as the fetal lung maturates, becoming ?????????????????????????????????????????? ?????? ????? ??????????? ????????????? ??? ????????
in vascular structures, namely smooth muscle or endothelial cells from both arterial and 
venous structures.
Ephrins-B1 and -B2, and EphB4 receptor protein expression levels were assessed by 
western blot analysis (Fig. 2). For the gestational ages studied, EphB4 receptor, ephrins-B1 
and -B2 expression was detected at relatively constant levels. Nevertheless, despite the 
higher variation in ephrin-B1 expression levels throughout all gestational ages, no statistical ???????????????????????? ??????????
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Ephrin-B1 and ephrin-B2 affect fetal lung morphogenesis in rat???????????????????????????????????? ????????????????????????????????????????????????????
studies were performed using lung explant cultures. Explants were daily supplemented 
with three different doses of either ephrin-B1 or ephrin-B2 recombinant protein (selected ?????????? ??? ????????????? ????????????? ????????? ????????? ?? ?????????????? ???????????? ???????
of both ligands on lung morphogenesis. Recombinant ephrin-B1 promoted an increase in ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
epithelial perimeter (Fig. 4 B and C, respectively). Moreover, ephrin-B2 treated explants 
present an increase in total lung area regardless of the dose studied (Fig. 4D).
Fig. 1. ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????-
ception (dpc). Ephrin-B2 and receptor EphB4 display a strong epithelial expression, while ephrin-B1 ex-????????? ??????????????????? ?????????????????????????????????????????????????????????????????????m (all ?????????????????????????????????????????????????????????????????????????????????????????????????????????
not shown).
Fig. 2. ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????-
rences between gestational stages.
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?????????????????????????????????????????????????????????????????????? ?????????? ????????? ????? ???? ??????????? ?????????? ???? ??????????? ?????????????
in lung morphogenesis, are poorly understood. In order to further investigate the effect 
of ephrins on fetal rat lung growth, treated lung explants were assessed for intracellular 
signaling pathways known to regulate lung growth and development.??????? ???????? ??? ????? ????????? ????????????? ?????????? ??? ???????????? ????????????? ??????? ??? ???????????? ?????????? ?????????? ?????????? ??? ???? ???????? ??????? ??? ?????????????? ??????????????????????? ?????????????????????????????? ?????????? ????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
Fig. 3. ?????????????????????????????????????????????????????????? ????????????????????????????????????-
amples of fetal lung explants cultured with three different doses of ephrin-B1 recombinant protein (0.01, 0.1 ??????????????????????????
0
) and day 4 (D
4
???????????? ?????????????????? ??????????????????????????????-?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????? ?????????????? ??????????????????????????????????????????? ???????? ??????????????????????????????????? m (all images at same mag-?????????????????????????????????????? ??????????????????????????????????????????
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Discussion 
There is growing evidence for the involvement of ephrins in numerous biological 
processes. Clearly, this family of proteins is implicated in regulation of key steps of embryonic 
development.  This study demonstrates that two ephrin ligands - B1 and B2 - and one well-
established ephrin-B2 receptor - EphB4 - are constitutively expressed during fetal lung 
development. Two recent studies presented strong evidence for the role of ephrin-B2 in lung ??????????????????????????????????? ????????????????????????????????????????????????????????
function but also show how yet another ephrin ligand promotes branching of the rat fetal 
lung.
The constitutive and stable protein expression levels of ephrins-B1 and -B2, and ?????? ????????? ????????????? ??????? ?????? ???????????? ???????? ?????? ???? ?????????????? ???
Fig. 4. ?????????????????????????????????????????????????????????????????????????????????????????????????
of fetal lung explants cultured with three different doses of ephrin-B2 recombinant protein (0.01, 0.1 and ??????????????????????
0
) and day 4 (D
4
?????????????????????????????????????????????????m (all images at ????? ??????????????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????-?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????
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???????? ????????????? ???? ??????? ??????????? ??????????? ????? ??? ?????????? ???????? ??????????????????????????????????????????????????????????????????????????????????????????????
two ligands suggest distinct or, perhaps, synergistic functions. Ephrin-B1 expression was 
Fig. 5. ?????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????? ????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????????????????-?????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
signaling pathways that mediate lung growth. No changes in activity levels of these pathways were observed ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
signaling pathways was measured by the ratio between phosphorylated protein and total protein amount. ????????? ???????????????????????????????????????????????????????????????????????????????????????????????
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mainly detected in mesenchymal tissue, whereas strong epithelial expression was found 
for ephrin-B2 and the receptor EphB4. Interactions between epithelial structures and the 
surrounding mesenchyme are known to dictate and to be essential for proper branching of ????????????????????????????? ?????????? ???????????????????????????? ????????????????????????
from this RTK subfamily of ligands to such mesenchymal-epithelial interactions that guide 
lung branching morphogenesis. ?????????????????????????????????????????????? ??????????????????????????????????????
[5, 6, 18, 19], epithelial expression of ephrin-B2 has been described in fetal mouse kidney 
and mammary gland [9, 11], also branching organs. Both ephrin-B1 and ephrin-B2 are also ????????????????????????????????????????????????????? ???????????????????????????????????
been observed in the epithelium. However, at 18 dpc ephrin-B2 was also expressed in some ??????????????????????? ???? ???????????????????????????????? ??????????????? ????????????????
In human fetal lung, ephrin-B2 is expressed in the pulmonary arterial endothelium and 
EphB4 expressed in endothelial cells of the pulmonary vein, primary capillary plexus and ??? ??????????????????? ??????? ?????????????????????????????????????? ???????????????????????
studied. These results are in agreement with observations from a recent knock-in mouse ?????? ??? ?????? ???? ?????????????? ??????? ??? ?????????? ???? ????????? ??? ?????????? ??????
sequences. The same study showed how ephrin-B2 reverse signaling blockage results in ??? ??????????????????????????????????????????????????????????????????????????? ??????????
both ephrins are enriched in the endothelial compartment [20]. The different observations 
in fetal lung might be due to the chosen study model and technical approach. Nevertheless, 
all together these observations suggest an intense endothelial-epithelial crosstalk played 
by these proteins since early stages of the fetal development to the adult organism. Indeed, 
vascular regulatory factors are crucial for airway and alveolar morphogenic processes. In 
fact, growth factors produced in the airway epithelium are able to regulate vasculature ???????????????????????????????????????????????????????????????????????????????????????????
-B2 would affect fetal lung growth and branching morphogenesis. 
In order to evaluate ephrins-B1 and -B2 role in lung branching morphogenesis, fetal 
lung explants were cultured with increasing doses of ephrin-B1 or ephrin-B2. Ephrin-B1 ???????????????? ??????????? ???? ?????????? ??? ??????????? ??????? ?????? ??????????????
ephrin-B2 supplementation increased not only lung branching but also the internal epithelial 
perimeter and area of the lung explants. These results strongly support a stimulatory role 
of ephrin-B1 and ephrin-B2 during fetal lung development. The importance of ephrins-B1 
and -B2 in different tissues during embryogenesis is highlighted by the lethality of ephrin-B1 
knockout mice [29] and angiogenesis impairment caused by ephrin-B2 gene disruption [5]. ???????????????????????????????????????????????????????????????????????????????????????????? ??? ??????????? ??? ??????? ?????????? ????????? ????????????? ???????? ????????? ????????????????????????????????????? ????????????? ?????????????????????????? ??? ????????? ???? ??????????????????? ????????????? ???? ??????? ??? ??????????? ?????????????????????????????????????????????????????????????????????????????? ???????????? ????
factors that regulate fetal lung branching morphogenesis activate signaling pathways that ??? ????????????????? ????????? ???? ???? ????????? ????? ???? ???????? ??? ???? ???????? ???????
ephrin-B1 was found not to modify the phosphorylated levels of these proteins. In a different ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
here studied cannot be rule out ?????????????????????????????????????????????????????????????????????????? ??? ????????? ???? ???????????????????????? ???????????????????? ?????? ???
would be interesting in future studies to access the role of this protein in the context of 
ephrin-B1 mediated fetal lung branching. Moreover, it would also be interesting to check if ????? ???????? ????? ??????????????????????????????????????????????????????????????????????????
changed when ephrin-B1 is administrated [45-49]. 
 In contrast, ephrin-B2 stimulation induced a decrease in phosphorylated levels of ????? ???? ???? ??????? ??????????? ?? ????????? ??? ?????? ?????????????? ??????????? ?????? ????????
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?????? ???????? ??????????? ?????? ??? ?????? ??????????? ??? ???????????? ?????? ??????????????????????????????????????????????????????????????????????????????????????????????????????
ERK, although classically this pathway has been implicated as a promoter of branching 
morphogenesis, it was already described that ERK pathway can be involved in lung growth 
inhibition [42, 50]. In a lung explant culture system similar to the one used in the present 
study, stimulation with leukemia inhibitory factor and concomitant activation of ERK pathway 
resulted in branching inhibition [50]. Recent published data has also shown that knockdown 
of ephrin-B2 results in increased phosphorylation levels of several kinases such as ERK, ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????? ???????????????????? ?????????????? ??? ?????
growth inhibition might still be an indirect or balancing effect of the activation of other 
pathways or simply context dependent. Further investigation will help to determine whether 
the inactivation of such pathways is essential for ephrin-B2 function in lung development or ?????????????????????????????????????????????? ???????????????????????????????????????????????
pathways.
In summary, this study demonstrated that both ephrin-B2 and its cognate receptor 
EphB4 are constitutively expressed in pulmonary epithelium, whereas ephrin-B1 is mainly 
expressed in the mesenchyme of the rat fetal lung. It is now clear that both ephrin-B1 and ??????????????????????????????????????? ?????????????? ?????????????????????????????? ???? ??
necessary to properly describe the expression pattern and functional contribution of other ????????????????????????????????????????????????????? ?????????????????????????? ???????????in 
vivo?????????????????????????????????????????????????????????????????????????????????????????
morphogenesis.
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ORIGINAL ARTICLE
Unique Tracheal Fluid MicroRNA Signature Predicts Response to
FETO in Patients With Congenital Diaphragmatic Hernia
Patrı´cia Pereira-Terra,∗† Jan A. Deprest, MD, PhD,‡ Ramin Kholdebarin, MD, MSc,∗ Naghmeh Khoshgoo,∗
Philip DeKoninck, MD, PhD,‡ Anne A. Boerema-De Munck,§ Jinxia Wang,¶ Fuqin Zhu,∗ Robbert J. Rottier, PhD,§
Barbara M. Iwasiow, MSc,∗ Jorge Correia-Pinto, MD, PhD,† Dick Tibboel, MD, PhD,§ Martin Post, DVM, PhD,¶
and Richard Keijzer, MD, PhD, MSc∗
Objective and Background: Our objective was to determine the fetal in vivo
microRNA signature in hypoplastic lungs of human fetuses with severe iso-
lated congenital diaphragmatic hernia (CDH) and changes in tracheal and
amniotic ﬂuid of fetuses undergoing fetoscopic endoluminal tracheal occlu-
sion (FETO) to reverse severe lung hypoplasia due to CDH.
Methods: We proﬁled microRNA expression in prenatal human lungs by mi-
croarray analysis. We then validated this signature with real-time quantitative
polymerase chain reaction in tracheal and amniotic ﬂuid of CDH patients
undergoing FETO. We further explored the role of miR-200b using semi-
quantitative in situ hybridization and immunohistochemistry for TGF-β2 in
postnatal lung sections.We investigatedmiR-200b effects on TGF-β signaling
using a SMAD-luciferase reporter assay and Western blotting for phospho-
SMAD2/3 and ZEB-2 in cultures of human bronchial epithelial cells.
Results: CDH lungs display an increased expression of 2 microRNAs: miR-
200b and miR-10a as compared to control lungs. Fetuses undergoing FETO
display increased miR-200 expression in their tracheal ﬂuid at the time of
balloon removal. Future survivors of FETO display signiﬁcantly higher miR-
200 expression than those with a limited response. miR-200b was expressed
in bronchial epithelial cells and vascular endothelial cells. TGF-β2 expres-
sion was lower in CDH lungs. miR-200b inhibited TGF-β-induced SMAD
signaling in cultures of human bronchial epithelial cells.
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Conclusions: Human fetal hypoplastic CDH lungs have a speciﬁc miR-
200/miR-10a signature. Survival after FETO is associated with increased
miR-200 family expression. miR-200b overexpression in CDH lungs results
in decreased TGF-β/SMAD signaling.
Keywords: congenital diaphragmatic hernia, miR-10a, miR-200, pulmonary
hypoplasia, TGF-β signaling, tracheal occlusion
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C ongenital diaphragmatic hernia (CDH) is a developmental de-fect of the diaphragm, allowing herniation of abdominal viscera
into the chest. It occurs in 1 in 2000 to 3000 live births.1 Although
postnatal treatment has become more standardized, substantial mor-
bidity and mortality result from the associated pulmonary hypoplasia
and abnormal vascular development of the newborn. A subset of fe-
tuses with liver herniation and a smaller lung size, represented by
an observed overexpected lung-to-head ratio (O/E LHR) under 25%,
has higher mortality and morbidity rates and, therefore, today are of-
fered in utero fetal surgery. Fetoscopic endoluminal tracheal occlusion
(FETO)2 prevents normal egress of airway ﬂuid, which in turn induces
tissue stretch, acting as a signal for lung growth. To stimulate lung
maturation, it was proposed to reverse the occlusion already in utero
(plug-unplug sequence),3 which also clinically seems to improve sur-
vival and morbidity.4,5 These preliminary observations are now being
evaluated in a randomized controlled trial [http://www.totaltrial.eu,
NIH NCT00763737 (moderate hypoplasia) and NIH NCT01240057
(severe hypoplasia)].6
A lack of understanding of the molecular mechanisms under-
lying pulmonary hypoplasia in CDH hampers progress for potential
in utero therapies and case selection. Although about 10% of CDH
patients have chromosomal anomalies, a common genetic cause for
CDH is unknown.7 However, it is widely accepted that the diaphrag-
matic defect and pulmonary hypoplasia result from a shared develop-
mental insult.8,9 MicroRNAs (miRNAs) are small noncoding RNAs
that regulate gene expression through posttranscriptional silencing of
messenger RNAs.10 MicroRNAs are essential for normal organogen-
esis during embryonic development. For example, targeted deletion of
miR-1 to 2 leads to congenital heart defects in mice.11 Previous stud-
ies have identiﬁed differential miRNA expression between various
stages of lung development, but these studies did not provide much
functional information.12 Whether speciﬁc miRNAs play a role in the
pathogenesis of human congenital lung diseases remains unknown.
Isolated CDH is characterized by abnormal lung development. The
ﬁrst objective of this study was to determine whether severe human
hypoplastic CDH lungs display speciﬁc microRNA expression. The
second objective was to determine if the obtained microRNA signa-
ture could be used as a biomarker, by evaluating its expression in
tracheal and amniotic ﬂuid samples of CDH patients before and after
forced lung growth. The third objective was to determine how abnor-
mal miR-200b expression inﬂuences target gene expression. This is
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the ﬁrst study to identify abnormal miR-200/miR10a expression in
hypoplastic CDH lungs and in response to forced lung growth. The
expression of these microRNAs in tracheal ﬂuid can be used to dis-
tinguish survivors of FETO from nonsurvivors. We also demonstrate
that increased miR-200b expression results in decreased target gene
expression via decreased TGF-β/SMAD signaling.
MATERIALS AND METHODS
MicroRNA Screen of Lung Specimens
RNA Isolation
Erasmus MC-Sophia’s institutional review board approved the
study protocol, and all the experiments were performed adhering to
the relevant guidelines of the Research Ethics Board of the University
ofManitoba. Surrogates provided consent for the use of human tissues
and bioﬂuids. We biopsied lungs from 3 fetuses with isolated and
severe CDH and 3 age-matched controls without lung disease (22,
22, and 25 weeks of gestation) undergoing termination or pregnancy.
Total RNAof these lung specimenswas extracted using Trizol reagent
(Invitrogen Life Technologies, Carlsbad, CA).
MicroRNA Profiling
The expression proﬁle of 319 humanmiRNAswas investigated
using a liquid-phase bead-based array according to themanufacturer’s
instructions. Five microgram of total RNA was biotinylated at the 3’
end using the FlexmiR MicroRNA labeling kit (Luminex, Austin,
TX). The labeled RNA was hybridized to locked nucleic acid (LNA)
capture probes. Each probe is bound to a ﬂuorescently dyed xMAP
bead. After washes, the biotinylated miRNAs were detected by reac-
tion with streptavidin-phycoerythrin. The samples were analyzed on
a Luminex-200 instrument. The measured intensities were subtracted
from a background control reaction and normalized against a set of
ubiquitously expressed small nucleolar RNAs (snoRNA). Heat maps
and statistical analyses were generated with the Institute for Genomic
Research MultiExperiment Viewer.
Real-Time Quantitative Polymerase Chain Reaction
Validation of MicroRNA Profile
We used the miRCURY LNA PCR system according to
the manufacturer’s instructions (Exiqon, Vedbaek, Denmark). LNA
primer sets were purchased from Exiqon (Table 1). After reverse
transcribing of the isolated RNAs, we used the SYBR Green assay
(Bio-Rad, Hercules, CA) for real-time quantitative polymerase chain
reaction (RT-qPCR) ampliﬁcation. We included 3 small RNA species
as endogenous controls (SNORD38B, 5S rRNA and U6 snRNA). Of
these, SNORD38B had the most stable expression between different
samples and was used to normalize the data.
Biomarker Screen of Biofluids (Amniotic and
Tracheal Fluids)
Clinical Evaluation
Ultrasound evaluation was performed less than 48 hours be-
fore FETO plug (further referred to as baseline, typically around
26–28 weeks) and less than 48 hours before balloon removal (typ-
ically around 34 weeks). The degree of pulmonary hypoplasia was
estimated using 2-dimentional ultrasound and was expressed as an
LHR as described before.13,14 The LHR is corrected for gestational
age by expressing the LHR of the index case as a proportion of
what is normally expected for a gestational age-matched normal
fetus (observed/expected: O/E LHR). The relative increase in O/E
LHR compared to the baseline value was expressed as follows: [(O/E
LHR unplug − O/E baseline)/O/E baseline] × 100%. In addition, a
functional status of the pulmonary circulation was evaluated using a
maternal hyperoxygenation test. The relative difference between pre-
and posthyperoxygenation valueswas expressed as deltaPI: [(baseline
PI − PIO2) / baseline PI] × 100%.
15,16
RNA Isolation
Amniotic and tracheal ﬂuid were collected at the time of bal-
loon insertion and its removal (n = 21). Amniotic ﬂuid was retrieved
at ﬁrst entry into the amniotic cavity; tracheal ﬂuid was sampled be-
low the vocal cords, through the fetoscopic sheath, taking care not
to contaminate it by irrigation ﬂuid. The Ethics Committee of the
UZ Leuven has approved the fetal treatment and prospective follow-
up program of patients with CDH, as well as the use of fetal ﬂuid
specimens to improve prenatal prediction of outcomes. We selected
archived (−80◦C) sample pairs from 11 consecutive “responders”
(deﬁned as having a marked increase in O/E LHR from baseline
and who were eventually surviving) and 10 “nonresponders” (ie,
poor or absent increase in lung size and eventually neonatal death17)
(Table 2).
Blinded to clinical outcome, total RNA was extracted for RT-
qPCR using the miRCURYRNA Isolation Kit for Bioﬂuids (Exiqon).
For normalization of sample-to-sample variation, 1 µL of synthetic
Caenorhabditis elegans miRNA (cel-miR-39) was added to each de-
natured sample.18,19 Small RNAs were then enriched and puriﬁed
according to the manufacturer’s protocol.
TABLE 1. LNA Primer Sets (Exiqon) Used in RT-qPCR
LNA MicroRNA Primer Set Target Sequence Description
SNORD38B TCTCAGTGATGAAAACTTTGTCCAGTTCTGCTACTG
ACAGTAAGTGAAGATAAAGTGTGTCTGAGGAGA
endogenous control
5S rRNA (hsa) GTCTACGGCCATACCACCCTGAACGCGCCCGATCTCGTCTGAT
CTCGGAAGCTAAGCAGGGTCGGGCCTGGTTAGTACTTG
GATGGGAGACCGCCTGGGAATACCGGGTGCTGTAGGCTTT
endogenous control
U6 snRNA (hsa, mmu) GTGCTCGCTTCGGCAGCACATATACTAAAATTGGA
ACGATACAGAGAAGATTAGCATGGCCCCTGCGCAA
GGATGACACGCAAATTCGTGAAGCGTTCCATATTTTT
endogenous control
hsa-miR-10a UACCCUGUAGAUCCGAAUUUGUG tested microRNA
hsa-miR-27a UUCACAGUGGCUAAGUUCCGC tested microRNA
hsa-miR-195 CCAAUAUUGGCUGUGCUGCUCC tested microRNA
hsa-let-7a CUAUACAAUCUACUGUCUUUC tested microRNA
hsa-miR-1 UGGAAUGUAAAGAAGUAUGUAU tested microRNA
hsa-miR-200b UAAUACUGCCUGGUAAUGAUGA tested microRNA
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Real-Time Quantitative Polymerase Chain Reaction
To optimize RT-qPCR performance, we did a dilution curve to
determine what input volume affected RT-qPCR performance. On the
basis of the outcome, 4µL of small RNAs from the bioﬂuids samples
were reverse transcribed using the miRCURY LNAUniversal RT mi-
croRNA PCR protocol (Exiqon) in a total reaction volume of 10µL.
The cDNA was diluted 1:40 µL in nuclease free water to be used
as a PCR template. PCR reactions for quantiﬁcation of miR-200a,
miR-200b, miR-200c, miR-141, miR-429, miR-10a, and cell-miR-39
were performed in triplicate and 20µl was used as the reaction vol-
ume. The RT-qPCR reactions were performed using an ABI 7500
Real-Time PCR System with the following cycling conditions: 95◦C
for 10 minutes, followed by 45 cycles of 95◦C for 10 seconds and
60◦C for 1 minute. The cycle threshold (Ct) values were calculated
with ABI 7500 v1.4.0 software. The target microRNAs sequences of
the LNA mix primers are summarized in Table 3.
Calculation of miRNA Expression
The average expression levels of amniotic and tracheal ﬂuid
miRNAs were normalized against cel-miR-3918,20,21 using the 2−!Ct
method. Differences between the groups are presented as !Ct, indi-
cating the difference between the Ct value of the miRNA of interest
and the Ct value of the normalizer miRNA. To ensure consistent
measurements and reproducibility throughout all assays, for each
PCR ampliﬁcation reaction, one of the RNA samples was loaded
in triplicate in all the plates, as internal control to account for any
plate-to-plate variation, and the results from each plate were also nor-
malized against an internal normalization control. The expression lev-
els of microRNAs were normalized with the C. Elegans cel-miR-39
Spike-in kit.
In Situ Hybridization and Immunohistochemistry
We obtained postmortem neonatal lung tissues from 3 post-
natal CDH cases and 3 age-matched controls, without lung disease
(35, 37, and 40 weeks of gestation). All cases died within 1 hour
after birth. In situ hybridization was carried out on 5 µm sections
of formalin-ﬁxed tissue as previously described.22 Our protocol was
ﬁrst validated with an LNA control probe against U6 snRNA. A
scramble-miR probe was used as a negative control and did not pro-
duce a signal. In situ hybridization with a probe against miR-10a
TABLE 2. Demographic Information for CDH Fetuses Undergoing FETO
Baseline Characteristics of the Embryos
Characteristics Responders (n = 11) Nonresponders (n = 10) P
O/E LHR at ﬁrst evaluation (%) 22.5 (23.6–17.5) 21.6 (24.0–15.9) 0.87
Liver herniated 10 (91%) 9 (100%) 1.00
Fetal gender (male/female) 7 (m)/4 (f) 4 (m)/5 (f) 0.65
FETO Pregnancy Data and Neonatal Outcome
FETO Data/Outcome Responders (n = 11) Nonresponders (n = 10) P
Gestational age at plug (wk) 28.1 (28.7–27.1) 27.9 (29.1–27.0) 0.84
Gestational Age at unplug (wk) 34.0 (34.1–33.4) 34 (34.5–33.9) 0.36
Occlusion days 39 (49–35) 43 (50–34) 0.64
Relative increase in O/E LHR 161.7 (252.4–140.8) 29.8 (10.4–50.2) <0.0001
Interval removal-delivery <24 h 1 (9%) 0 (0%) 1.00
PPROM 5 (45%) 3 (33%) 0.67
Gestational Age at PPROM (wk) 35.0 (35.9–32.6) 35.4 (36.6–29.3) 1.00
Gestational Age at delivery (wk) 37.0 (38.0–35.0) 38.0 (38.4–36.4) 0.25
Birth weight (g) 2780 (3180–2160) 3195 (3278–2650) 0.30
Oxygen at day 28 6 (55%) NA
NICU days 45 (61–30) NA
Day of neonatal death NA 1 (2–0)
All median (IQR) or n (%).
NA indicates not applicable. NICU indicates neonatal intensive care unit; PPROM, preterm premature rupture of membranes.
TABLE 3. MicroRNA Target Sequences for RT-qPCR and LNA Probes (Exiqon) Used for In Situ Hybridization
Target MicroRNA Sequence
hsa-miR-200a-3p UAACACUGUCUGGUAACGAUGU
hsa-miR-200b-3p UAAUACUGCCUGGUAAUGAUGA
hsa-miR-200c-3p UAAUACUGCCGGGUAAUGAUGGA
hsa-miR-141-3p UAACACUGUCUGGUAAAGAUGG
hsa-miR-429 UAAUACUGUCUGGUAAAACCGU
hsa-miR-10a-5p UACCCUGUAGAUCCGAAUUUGUG
cel-miR-39-3p UCACCGGGUGUAAAUCAGCUUG
Probe Sequence Concentration Hybridization Temperature
hsa-miR-200b TCATCATTACCAGGCAGTATTA 100 nM 52◦C
hsa-miR-10a CACAAATTCGGATCTACAGGGTA 100 nM 53◦C
scramble-miR GTGTAACACGTCTATACGCCCA 100 nM 57◦C
U6, positive control CACGAATTTGCGTGTCATCCTT 0.1 nM 54◦C
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produced a very weak signal in postnatal lung tissues. MicroRNA
species were hybridized with double-digoxigenin-labeled LNA
probes (Exiqon) for 1 hour (Table 3). We detected the hybridized
probes with an alkaline phosphatase–conjugated antidigoxigenin an-
tibody (1:500) (Roche, Mannheim, Germany). Sections were im-
munostained with 1-step NBT/BCIP solution, containing 1 mM lev-
amisole (Thermo Scientiﬁc, Rockford, IL). The slides were coun-
terstained with methyl green (Sigma-Aldrich, St Louis, MO). We
performed immunohistochemistry on neonatal lung tissue using an
anti-TGF-β2 antibody (1:100) (Abcam, Cambridge, MA) as previ-
ously described.23
Microscopy and Image Analysis
Digital microscopy was performed with the ScanScope CS
system (Aperio, Vista, CA). Semiquantitative measurements of the
in situ hybridization studies were obtained as follows. Images up to
200× magniﬁcation were obtained and analyzed using ImageScope
software (http://www.aperio.com). The entire area of each lung sec-
tion was digitally mapped using the colocalization algorithm. The
blue and green stainings were ﬁrst calibrated with the color deconvo-
lution tool using positive (U6 probe without counterstain) and nega-
tive (scramble probe with methyl green counterstain) control slides,
respectively. The average optical densities of each stain in the red,
blue, and green channels were then entered into the colocalization
algorithm. The program creates a digital map of the slide made up of
3 colors: blue for positive staining, green for nuclear counterstaining,
and aqua for colocalized blue and green staining. This digital map
was visually checked against the original image to ensure accuracy.
The program outputs the area of each color as a percentage of all 3
colors. Positive staining was calculated by adding the percentages of
blue and aqua (% positive staining).
Luciferase Assay
Weused the Cignal SMADReporter kit (SABiosciences, Fred-
erick, MD) to investigate the effects of miR-200b on the TGF-β-
induced signal transduction pathway.24 The construct encodes the ﬁre-
ﬂy luciferase reporter gene under the control of a minimal (m)CMV
promoter and tandem repeats of the SMAD transcriptional response
element. The assay was carried out according to the manufacturer’s
instructions. Cultured human bronchial epithelial cells, BEAS-2B
(ATCC, Manassas, VA), were cotransfected with 0.5 µg/mL of the
SMAD reporter construct and 0.01µg/mLof LNA-oligonucleotide—
inhibitor, mimic, or control (Exiqon)—using the X-tremeGENE
siRNA Transfection Reagent (Roche). After 48 hours, luciferase ac-
tivity was measured with a Dual-Luciferase Reporter Assay System
(Promega, Madison, WI).
Western Blots
BEAS-2B cells were transfected with 0.01 µg/mL of LNA-
oligonucleotides. After 48 hours, the cells were washed and protein
extracts were prepared in lysis buffer: 10 mM Tris-HCl (pH 6.8),
5 µM β-glycerophosphate, 20 µM EDTA, 5% SDS, a protease in-
hibitor cocktail tablet, and phosphatase inhibitors (1 mM sodium
orthovanadate, 2 mM EDTA, 10 mM sodium pyrophosphate, 30 mM
sodium chloride). The supernatant protein concentration was deter-
mined using RC DC Protein Assay (Bio-Rad, Hercules, CA). Fifteen
micrograms of total protein was reduced with mercaptoethanol, size
fractionatedwith SDS-PAGE and transferred to a nitrocellulosemem-
brane (Bio-Rad). Speciﬁc proteins were detected with the following
antibodies: anti-SMAD2/3 (1:750) (Cell Signaling, Danvers, MA),
anti-phospho-SMAD2 (1:750) (Cell Signaling), anti-ZEB2 (1:500)
(Santa CruzBiotechnology, Santa Cruz, CA), anti-GAPDH (1:10000)
(Abcam). Primary antibodies were detected using HRP-conjugated
goat–anti-rabbit antibody (1:7000) (Bio-Rad) and HRP-conjugated
goat–anti-mouse antibody (1:7000) (Bio-Rad). Exposed ﬁlms were
scanned and band densities were obtained after background subtrac-
tion using ImageJ software in a blinded fashion. Band densities were
normalized against the corresponding GAPDH values.
Statistical Analysis
All quantitative data are presented as mean ± standard error
of the mean or median and interquartile range (IQR) where appropri-
ate. Statistical analyses were performed using the statistical software
SigmaStat (version 3.5; Systat Software Inc). Statistical comparisons
were performed using the unpaired Student t test and nonparametric
Mann-Whitney U test where appropriate. Paired analysis was per-
formed using a Wilcoxon signed rank test. Differences were consid-
ered signiﬁcant at P < 0.05.
RESULTS
miR-200b and miR-10a Expression Are Increased
in Fetal Hypoplastic CDH Lungs
The expression proﬁle of the 319 human miRNAs tested is
shown as a heat map in Figure E1 of the online data supplement
(available at http://links.lww.com/SLA/A738). Two miRNAs, miR-
200b and miR-10a, were more abundant in prenatal hypoplastic CDH
lungs compared to age-matched normal control lungs (P < 0.01) (Fig.
1A). Both miR-200b and miR-10a had an approximately threefold
greater expression in CDH lungs compared to age-matched control
lungs (Fig. 1B). Four other miRNAs—miR-27a, miR-195, let-7a,
and miR-1—were tested on the basis of near signiﬁcant differences
in the microarray analysis (Fig. E1, available at http://links.lww.com/
SLA/A738). None of these had a statistically signiﬁcant difference in
expression in CDH lungs compared to control lungs using RT-qPCR
(results not shown).
Tracheal Fluid: Responders Have Higher Expression
of miR-200 Than Nonresponders After FETO
On the basis of these observations, we focused on validating
and further exploring the expression of the miR-200 family (miR-
200a, miR-200b, miR-200c, miR-141, and miR-429) and miR-10a
in tracheal and amniotic ﬂuid samples of CDH patients at baseline
(plug) as well as following forced lung growth by FETO (unplug). Re-
sponders (ie, with measurable lung growth and eventually surviving)
to FETO had increased expression of the miR-200 family in their tra-
cheal ﬂuid. Expression of miR-200 was higher after FETO (unplug)
in responders compared to nonresponders (Figs. 2A–E). However,
their baseline expression was not different. Conversely, tracheal ﬂuid
miR-10a expression was lower in responders than in nonresponders
at baseline (plug). After FETO (unplug), the expression of miR-10a
increased in responders but remained unchanged in nonresponders
(Fig. 2F).
Expression of miR-200 Family and miR-10a
in Amniotic Fluid Decreases After FETO
After FETO (unplug), the amniotic ﬂuid levels of the investi-
gated miRNAs did not mirror what was observed in the tracheal ﬂuid.
The amniotic ﬂuid levels were overall lower. Because the lungs con-
tribute largely to the amniotic content in the third trimester and were
occluded during FETO, this was anticipated.25 The expression pro-
ﬁles of all investigated microRNAs exhibited a similar trend: FETO
responders had signiﬁcantly higher expression than nonresponders
(Fig. 3). More speciﬁcally, expression of miR-200a and miR-200c
signiﬁcantly decreased after FETO (unplug) (Figs. 3A and C). Ex-
pression of miR-200a, miR-200c, miR-141, and miR-10a was higher
in amniotic ﬂuid of survivors than in nonsurvivors after FETO (un-
plug) (Figs. 3A, C, D, and F).
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FIGURE 1. Upregulation of miR-200b and miR-10a in prenatal lungs in CDH. Total RNA was extracted from 3 CDH cases and
3 age-matched controls (Ctrl). A, Heat map representation of normalized microarray data (log 2 scale). Of the 319 miRNAs
tested, miR-200b and miR-10a were overexpressed in hypoplastic lungs (P < 0.01). B, Real-time PCR confirmed overexpression
of miR-200b and miR-10a in CDH (∗P < 0.05). miRNA expression is normalized relative to SNORD38B (U38B).
A Good Pulmonary Response After FETO Also Alters
Pulmonary Vascular Reactivity to Oxygen
The median relative increase in O/E LHR in fetuses surviv-
ing after birth was signiﬁcantly higher than in nonresponders [161.7
(IQR: 252.4–140.8) vs 29.8 (IQR: 10.4–50.2); P < 0.0001] (Table 2).
Vascular reactivity could be assessed in 4 of 10 poor responders and 6
of 11 good responders. In fetuses with poor response after FETO, we
did not observe a change in median deltaPI [−2.0% (IQR: −10.3 to
31.0) vs 13.6% (IQR: 1.3–28.2); P = 0.63]. In contrast in fetuses with
a good response, median deltaPI increased signiﬁcantly after FETO
[4.6% (IQR: −1.3 to 11.9) vs 23.0% (IQR: 3.4–39.8); P = 0.03].
Expression of miR-200b Is Higher in the Distal Part
of Postnatal Hypoplastic Lungs
We performed in situ hybridization to determine miR-200b ex-
pression in a separate set of postnatal lung sections. Hypoplastic CDH
lungs were characterized by increased miR-200b expression, partic-
ularly in the terminal saccules and alveoli (Fig. 4A). We used image
analysis software to generate color-coded maps and quantify the area
of positive staining for each lung section. Using this method, neona-
tal hypoplastic CDH lungs displayed increased miR-200b expression
compared to age-matched control lungs (Fig. 4B).
In situ hybridization for miR-200b produced a highly speciﬁc
staining pattern in normal neonatal lungs. Bronchial epithelial cells
were intensely positive for miR-200b (Fig. 4C, thick black arrow). In
contrast, parabronchial smooth muscle cells were predominantly neg-
ative for miR-200b (Fig. 4C, thick white arrow). Terminal saccules
contained a mixed population of positive (alveolar type II cells) and
negative-staining cells. In blood vessels, endothelial cells (inner layer)
were positive for miR-200b (Fig. 4C, black arrowhead). Perivascu-
lar smooth muscle cells, on the other hand, were negative (Fig. 4C,
white arrowhead). Mesothelial cells of the pleura were positive for
miR-200b (results not shown).
TGF-β2, a miR-200b Target Gene, Expression Is
Decreased in Hypoplastic CDH Lungs
Others have identiﬁed components of the TGF-β-induced sig-
nal transduction pathway as themajor targets of themiR-200 family.26
Weused immunohistochemistry to assess TGF-β2 expression in post-
natal lung tissues. The cellular distribution of TGF-β2 was very sim-
ilar to miR-200b, that is, expressed in bronchial epithelial cells and
vascular endothelial cells, but absent from parabronchial and perivas-
cular smooth muscle cells. CDH lungs displayed decreased TGF-β2
expression in terminal saccules compared to age-matched control
lungs (Fig. 5A).
miR-200b Downregulates TGF-β Signaling in Human
Bronchial Epithelial Cells
Downstream effects of TGF-β-induced signal transduction
are initiated through SMAD2/3 phosphorylation and its subsequent
nuclear translocation.27 We used a luciferase bioluminescent assay
to measure SMAD-induced gene expression and the impact of
changing miR-200b expression in cultures of human bronchial ep-
ithelial cells. In a pilot experiment measuring miR-200b expression
in different cell lines relevant to lung, we demonstrated that these
cells exhibit abundant miR-200b expression (results not shown). In
absence of exogenous TGF-β, bronchial epithelial cells displayed
very little SMAD-dependent luciferase activity. This low baseline
activity did not change when miR-200b mimics were added to the
culture medium. On the contrary, inhibitors of miR-200b increased
SMAD-luciferase activity by several orders of magnitude (Fig. 5B).
Collectively, these data suggest that basal TGF-β-induced signaling
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FIGURE 2. miR-200 family members and miR-10a expression analysis in tracheal fluid samples of surviving and nonsurviving
patients with CDH undergoing FETO. Expression levels of miR-200a (A), miR-200b (B), miR-200c (C), miR-141 (D), miR-429 (E),
and miR-10a (F) in tracheal fluid samples. Expression levels of these microRNAs were normalized to cel-miR-39. Statistical analysis
was performed using the Mann-Whitney U test for independent comparisons between surviving and non-surviving patients and
a Wilcoxon signed-rank test for paired comparisons between plug and unplug, ∗P < 0.05; †P < 0.01; ‡P < 0.001.
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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FIGURE 3. miR-200 family members and miR-10a expression analysis in amniotic fluid samples of surviving and nonsurviving
patients with CDH undergoing FETO. Amniotic fluid levels of miR-200a (A), miR-200b (B), miR-200c (C), miR-141 (D), miR-429
(E), and miR-10a (F). Expression levels of these microRNAs were normalized to cel-miR-39. Statistical analysis was performed
using the Mann-Whitney U test, for independent comparisons between surviving and non-surviving patients and a Wilcoxon
signed-rank test for paired comparisons between plug and unplug, ∗P < 0.05; †P < 0.01.
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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FIGURE 4. In situ hybridization for miR-200b (blue stain) in postnatal lung (methyl green counterstain, 200× magnification).
A, Terminal saccules of control vs CDH lungs (color-coded maps: blue = positive staining, green = negative staining, aqua =
colocalized positive and negative staining). B, Area of positive staining (% blue +% aqua) was calculated for each lung section
(∗P < 0.05). C, miR-200b expression in normal postnatal lung. In bronchioles, miR-200b is expressed in epithelial cells (black
thick arrow), but is absent from parabronchial smooth muscle cells (white thick arrow). In blood vessels, miR-200b is expressed in
endothelial cells (black arrowhead) but is absent from the surrounding smooth muscle cells (white arrowhead). Terminal saccules
contain a mixed population of miR-200b-positive (black thin arrow) and miR-200b-negative (white thin arrow) cells.
is tempered by steady state levels of miR-200b, and that reducing
miR-200b is permissive for TGF-β-induced signaling.
To clarify mechanisms that might underpin altered basal
SMAD-mediated responses, we next performed Western blotting
using antibodies against total SMAD2/3 and phospho-SMAD2/3
(p-SMAD). Addition of miR-200b inhibitors or mimics to cultures
of bronchial epithelial cells resulted in a nearly twofold increase or
decrease, respectively, in p-SMAD levels; however, total SMAD2/3
abundance was unaffected (Fig. 5C). ZEB2 is a downstream transcrip-
tional repressor in the TGF-β/SMAD signal transduction pathway and
a putative target of miR-200b based on sequence complementarity.27
Addition of miR-200b inhibitors or mimics to cultures of bronchial
epithelial cells resulted in a nearly twofold increase or decrease, re-
spectively, in ZEB2 levels (Fig. 5C).
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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FIGURE 5. miR-200b Target Gene Expression. A, Immunohistochemistry for TGF-β2 (brown stain) in control vs CDH postnatal
lungs (hematoxylin counterstain, 200× magnification). B, SMAD-luciferase reporter assay in cultures of bronchial epithelial cells.
Luciferase activity was measured after a 48-hour incubation with miR-200b inhibitor, mimic, or control oligonucleotide. C,
Immunoblotting for ZEB2 and phospho-SMAD (p-SMAD). Bronchial epithelial cells were incubated for 48 hours with miR-200b
inhibitor, mimic, or control oligonucleotide (∗P < 0.05).
DISCUSSION
The lack of success in identifying a pure genetic cause for CDH
prompted us to investigate the role of epigenetics and more in partic-
ular microRNAs. Our study is the ﬁrst to demonstrate altered miRNA
expression in human congenital lung disease. Homogenates of hy-
poplastic lungs from CDH fetuses display miR-200b and miR-10a
overexpression. We then selected tracheal and amniotic ﬂuid samples
from fetuses with appropriate or insufﬁcient lung growth after fe-
tal surgery. Responders could be discriminated from nonresponders
by a signiﬁcantly higher miR-200 expression in their tracheal ﬂuid,
suggesting that stimulated lung development is associated with an
increase in miR-200 expression. Upregulation of miR-200b persists
in terminal saccules of CDH patients and is associated with decreased
TGF-β2 expression. In vitro, miR-200b inhibits TGF-β/SMAD sig-
naling in bronchial epithelial cells.
Using in situ hybridization, we determined that miR-200b
is overexpressed in the terminal saccules of postnatal CDH lungs
compared to age-matched controls. miR-200b is a member of the
miR-200 family, including also miR-200a, miR-200c, miR-141,
and miR-429.26,28–32 These miRNAs have similar sequences and
are transcribed in 2 clusters: miR-200b, miR-200a, and miR-429
share a common transcription start site on chromosome 1, whereas
miR-200c and miR-141 are transcribed as a single unit from
chromosome 12. There is increasing evidence that members of
the miR-200 family play a role in cancer. Several studies have
demonstrated that miR-200 expression is upregulated in epithelial
tissues, where they contribute to the epithelial cell phenotype by
inhibiting mesenchymal gene expression.29 We observed strong
miR-200b expression in bronchial and alveolar epithelial cells. In
contrast, parabronchial smooth muscle cells, which are differentiated
mesenchymal cells, were negative for miR-200b. Mesothelial and
endothelial cells were also positive for miR-200b.We have previously
demonstrated that hypoplastic CDH lungs are characterized by a
disturbed epithelial/ﬁbroblast cell ratio in favor of ﬁbroblasts.23
The miR-200 family functions by inhibiting several genes in-
volved in the TGF-β/SMADsignaling pathway.26,33 IncreasedTGF-β
activity enhances miR-200 expression as part of a negative feed-
back loop.34 Others have previously demonstrated in the surgical
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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sheep model of CDH that FETO increased TGF-β2 expression in hy-
poplastic lungs.35 In addition, increased TGF-β expression has been
observed in hypoplastic lungs in the nitrofen-induced rat model of
CDH.36–38 Here, we observed increased miR-200 expression in pre-
natal and postnatal lung tissues in CDH and tracheal ﬂuid samples of
CDH patients responding to FETO. Our data suggest that the increase
in miR-200 might result from an inherent increased TGF-β expres-
sion in hypoplastic lungs. In addition, FETO can increase miR-200b
expression even further in lungs responding to mechanical stretch
via upregulation of TGF-β expression in these lungs. The primary
insult leading to CDH and pulmonary hypoplasia occurs very early
in gestation when a diagnosis cannot be made yet.39,40 Because of
the unavailability of human fetal tissues during these early stages of
lung development, we were unable to investigate miRNA or TGF-β
expression at the time of the primary insult. In postnatal lung tis-
sues of CDH cases, we observed decreased TGF-β2 expression, par-
ticularly in the terminal saccules. During fetal lung development,
endogenous TGF-β blocks hormone-induced type II epithelial cell
differentiation.41 Decreased TGF-β activity in late stages of lung
development might explain why human cases of CDH display nor-
mal surfactant maturation.42,43 In addition, exogenous surfactant has
been demonstrated to be of no beneﬁt in the treatment of pulmonary
hypoplasia associated with CDH.44,45
We established the inhibitory effect of miR-200b on TGF-β/
SMAD signaling in human bronchial epithelial cells. Given their
epithelial phenotype, these cells displayed a very low level of intrin-
sic SMAD2/3 activity. miR-200b inhibition signiﬁcantly enhanced
SMAD2/3 phosphorylation, suggesting that in bronchial epithelial
cells, miR-200b functions by suppressing endogenous TGF-β activ-
ity. Both increased and decreased TGF-β signaling can lead to abnor-
mal lung development.46–48 Our results suggest that miR-200b plays
an important role in normal lung development by closely regulating
TGF-β signaling.
Extracellular microRNAs have recently emerged as potential
biomarkers because they have been shown to be associated with
various pathological conditions including cancer. Biomarkers have
also successfully been used to stratify therapy and/or to evaluate re-
sponse to therapy. Both miR-200 and miR-10a have earlier served as
biomarkers in some conditions. Most of these studies have focused on
their role in cancer progression. Increased serum miR-200c expres-
sion is associated with colorectal cancer progression and metastasis49
and gastric cancer.50 In contrast, decreased miR-200a expression is
associated with poor prognosis and recurrence in ovarian cancer.51
The role of miR-10a as a biomarker is less well established. A recent
study showed overexpression of miR-10a in human pancreatic can-
cer cells.52 Furthermore, a combination of miR-10a and miR-200b
has recently been reported to be a valuable microRNA signature for
metastatic medullary thyroid carcinoma53 and bladder cancer.54 We
have shown that tracheal ﬂuid expression of miR-200 and miR-10a
can serve as amarker of response to FETO.Although FETOdecreased
amniotic miRNA expression, survivors could be distinguished by
higher expression of miR-200a, miR-200c, miR-141, and miR-10a.
Considering our study limitations, we are aware that this study
has a relatively small sample size, no detailed phenotypic informa-
tion on the termination of pregnancy patients, a narrow window of
gestational age in the FETO group and most importantly, no control
amniotic or tracheal ﬂuids. For obvious reasons, it would be unethical
to try and obtain tracheal ﬂuid samples from control patients. The
ﬁrst experiment was carefully planned to include only prenatal lungs
for identiﬁcation of potential microRNAs as etiological factors of
pulmonary hypoplasia in CDH. CDH is typically diagnosed at sec-
ond trimester ultrasound55 and therefore, our 3 pairs of prenatal CDH
and control lungs (22–25 weeks of gestation) form a unique homoge-
nous set of severely hypoplastic lungs, which were not exposed to
confounding pre- or postnatal factors directly interfering with lung
development (steroids, ventilation, etc). These lungs were obtained
from terminations of pregnancies for medical reasons and processed
for research purposes within 1 hour of termination. In addition, the
tracheal and amniotic ﬂuid samples were carefully collected as part
of a systematic collection of bioﬂuids in a very well characterized
homogenous group of patients undergoing FETO.
CONCLUSIONS
We are the ﬁrst to report altered microRNA expression in clin-
ical cases with abnormal lung development due to severe isolated
CDH. Future studies should reveal if manipulating miR-200 and
miR-10a expression improves the natural course in CDH patients
and their abnormal lung development.
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KEY POINTS: 
 
1) Retinoic Acid (RA) and Ghrelin levels are altered in human hypoplastic 
lungs when compared to healthy lungs. Although there are many data about 
RA, ghrelin and bombesin in CDH rat model, neuroendocrine factors have 
never been associated with RA signalling pathway in this animal model. 
2) In this study, the interaction between neuroendocrine factors and RA was 
explored in the CDH rat model.  
3) The authors’ results indicate that normal foetal lung explants treated with 
RA, bombesin and ghrelin present an increase in lung growth. Hypoplastic 
lungs presented higher RAR α/γ expression levels. Moreover bombesin and 
ghrelin supplementation, in vitro, to normal lungs increased RAR 
α/γ expression whereas bombesin and ghrelin antagonists administration to 
normal and hypoplastic lungs decreased it. 
4) This data reveals for the first time that there is a link between 
neuroendocrine factors and RA, and that neuroendocrine factors sensitize 
the lung to the RA action through RAR modulation.  
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ABSTRACT  
 
Congenital diaphragmatic hernia (CDH) is characterised by a spectrum of 
lung hypoplasia and consequent pulmonary hypertension, leading to high 
morbidity and mortality rates. Moreover, CDH has been associated with an 
increase in the levels of pulmonary neuroendocrine factors, such as 
bombesin and ghrelin, and a decrease in the action of retinoic acid (RA). The 
present study aimed to elucidate the interaction between neuroendocrine 
factors and RA. 
To determine the link between neuroendocrine factors and RA, in vitro 
analyses were performed on Sprague Dawley rat embryos. Normal lung 
explants were treated with bombesin, ghrelin, a bombesin antagonist, a 
ghrelin antagonist, dimethylsulfoxide (DMSO), RA dissolved in DMSO, 
bombesin plus RA and ghrelin plus RA. Hypoplastic lung explants (nitrofen 
model) were cultured with bombesin, ghrelin, bombesin antagonist or ghrelin 
antagonist. The lung explants were analysed morphometrically, and retinoic 
acid receptor (RAR) α, β and γ expression levels were assessed via Western 
blotting. Immunohistochemistry analysis of RAR was performed in normal 
and hypoplastic E17.5 lungs. 
Compared with the controls, hypoplastic lungs exhibited significantly higher 
RARα/γ expression levels. Furthermore considering hypoplastic lungs, 
bombesin and ghrelin antagonists decreased RARα/γ expression. Normal 
lung explants (E13.5) treated with RA, bombesin plus RA, ghrelin plus RA, 
bombesin or ghrelin exhibited increased lung growth. Moreover, bombesin 
and ghrelin increased RARα/γ expression levels, whereas the bombesin and 
ghrelin antagonists decreased RARα/γ expression. 
This study demonstrates for the first time that neuroendocrine factors 
function as lung growth regulators, sensitising the lung to the action of RA 
through up-regulation of RARα and RARγ. 
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INTRODUCTION: 
 
Congenital diaphragmatic hernia (CDH) is a severe developmental anomaly 
with a mean incidence of 1:3000 live births whose aetiology remains poorly 
understood (Van den Hout et al., 2009; Keller et al., 2010; Nogueira-Silva et 
al., 2011). This congenital anomaly is characterised by a diaphragmatic 
defect that allows intra-thoracic herniation of abdominal organs and 
maldevelopment of the alveoli and pulmonary vessels (Van Loenhout et al., 
2009). Thus, new-borns with CDH develop pulmonary hypoplasia and 
pulmonary hypertension (PH) and, consequently, severe respiratory failure. 
In fact, among the known causes of severe respiratory failure in new-borns, 
CDH remains the most life threatening (Goshe et al., 2005). 
Despite the increased understanding of the pathophysiology of CDH and 
recent advances in neonatal care, CDH remains a challenging condition that 
is associated with high morbidity and mortality rates (Pereira-Terra et al., 
2015; Pereira-Terra et al, in press). Thus, the development of a less invasive, 
safer and cheaper approach with minimum risk to the mother and the foetus 
is crucial (Leeuwen and Fitzgerald, 2014). To this end, a search for less 
invasive antenatal approaches that promote foetal lung growth has emerged. 
Retinoic acid (RA), an active metabolite of vitamin A, binds to specific RA 
receptors (RARs and RXRs) and functions as an essential signal for lung 
growth and differentiation (Thébaud et al., 1999). Indeed, RA is involved in 
various phenomena related to lung morphogenesis, including the formation 
of the lung primordium, distal bud outgrowth, differentiation of epithelial cells 
and the distal mesenchyme, and promotion of alveolisation by inducing the 
formation of secondary septae. Additionally, the retinoid signalling pathway 
has been shown to be involved in CDH pathophysiology. For example, 
decreased plasma levels of retinol and retinol-binding protein are observed in 
individuals with CDH (Major et al., 1998). Furthermore, CDH has been 
observed in patients with deletions within chromosome 15q, which contains 
the gene encoding cellular retinoic acid binding protein (CRABP1) (Pober, 
2007). In animal studies, double RAR knockouts (RARα and RARβ 
knockouts) were shown to exhibit unilateral lung agenesis and contralateral 
lung hypoplasia (Mendelsohn et al., 1994; Beurskens et al., 2009). Moreover, 
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in a nitrofen-induced CDH rat model, which is the best animal model 
mimicking CDH, inhibition of the RA signalling pathway was reported to 
occur, and rescue of nitrofen-induced PH in foetal rat lungs was observed 
upon maternal administration of RA (Thébaud et al., 1999; Antipatis et al., 
1998; Ruttenstock et al., 2011; Sugimoto et al., 2008; Asabe et al., 1999; Doi 
et al., 2010; Baptista et al., 2005). The neuroendocrine factors bombesin and 
ghrelin are produced by pulmonary neuroendocrine cells (PNECS) and 
appear to play important roles in lung development and maturation from 
intrauterine life to the postnatal period (Asabe et al., 1999). Furthermore, 
CDH has been associated with an increased bombesin and ghrelin levels. 
Moreover early maternal administration of ghrelin during gestation was 
shown to attenuate pulmonary hypoplasia in a CDH animal model (Santos et 
al. 2006, Cutz et al., 2007). Therefore, the aim of this study was to evaluate 
the putative association between neuroendocrine factors (bombesin and 
ghrelin) and RA during normal and hypoplastic foetal lung development. 
 
 
MATERIALS AND METHODS: 
 
Ethical approval: 
Animal experiments were performed according to the Portuguese law for 
animal welfare (Diário da República, Portaria 1005/92). Animals were housed 
in an accredited animal facility and treated as specified by the 
recommendations of the NIH guidelines and the Guide for the Care and Use 
of Laboratory Animals, published by the National Academy Press (Doi et al., 
2010; Baptista et al., 2005). 
 
 
Animal model and experimental design: 
Female Sprague Dawley rats (225 g; Charles River, Barcelona, Spain) were 
maintained in appropriate cages under controlled conditions and fed with 
commercial solid food. The rats were mated and checked daily for vaginal 
plugs. The day of plugging was defined as gestational day 0.5 for the 
purpose of time dating. According to the nitrofen-induced CDH rat model, 
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randomly selected pregnant rats received 100 mg of nitrofen (2,4-
dichlorophenyl-p-nitrophenylether) dissolved in 1 ml of olive oil via gavage on 
gestational day 9.5 dpc (days post-conception) (hypoplastic group - N) 
(Nogueira-Silva et al., 2011). Control animals only received only olive oil 
(control group - C). The dams were anaesthetized with pentobarbital 
overdose (150mg/kg intraperitonial) followed by decapitation. After that, the 
foetuses were removed through Caesarean section and euthanized by 
decapitation. For lung explant cultures, the foetuses were harvested, and 
their lungs were dissected at 13.5 dpc and incubated with different 
compounds or inhibitors (Table 1) and at 17.5 dpc for immunohistochemistry. 
 
Table 1: Schematic representation of the study design. 
 
 
Immunohistochemistry (IHC): 
Immunostaining was performed in formalin-fixed and paraffin-embedded 
control and hypoplastic lungs at 17.5 dpc, as previously described (Nogueira-
Silva et al., 2012). All the slides were stained during the same time. The 
RARα antibody (Santa Cruz Biotechnology Inc, Heidelberg, Germany) was 
used at a 1:200 dilution, the RARβ antibody (Santa Cruz Biotechnology Inc.) 
at a 1:50 dilution, and the RARγ antibody (Abcam at a 1:100 dilution. 
Incubation with UltraVision detection system anti-polyvalent horseradish 
peroxidase (Lab Vision Corporation) was carried out according to the 
manufacturer’s instructions. Omitting the primary antibodies negative controls 
were performed. The slides were photographed with an Olympus BX61 
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microscope (Olympus, Tokyo, Japan). At least three independent 
experiments were performed. 
 
Foetal lung explant culture 
Control and hypoplastic lungs were removed from 13.5 dpc embryos, 
harvested and dissected in DPBS (Lonza) under a dissection microscope 
(SZX16, Olympus). The lungs were then transferred to Nucleopore 
membranes (IsoporeTM membrane filters, Millipore) and cultured for 4 days 
as previously described (Piairo et al., 2011). 
The control and hypoplastic lung cultures were supplemented daily with 1 µM 
bombesin (Tocris Bioscience) (Kresch et al., 1999) or 30 nM ghrelin 
(Peptides international, Louisville) (Nunes et al., 2008) and with one of the 
following treatments: 10-6 M RA (Sigma) dissolved in 0.1% dimethylsulfoxide 
(DMSO), 0.1% DMSO alone, 1 µM bombesin plus 10-6 M RA, 30 nM ghrelin 
plus 10-6 M RA, 10-7 M bombesin antagonist (Phoenix Pharmaceuticals) 
(Hosli et al., 1993) or 10-6 M ghrelin antagonist (Bachem AG) (Nunes et al., 
2008). Thus, this set of experiments included the following 14 groups: control 
(n=27), control plus ghrelin (n=27), control plus bombesin (n=27), control plus 
ghrelin antagonist (n=27), control plus bombesin antagonist (n=27), control 
plus DMSO (n=27), control plus RA dissolved in DMSO (n=27), control plus 
bombesin and RA (n=27), control plus ghrelin and RA (n=27), nitrofen 
(n=27), nitrofen plus ghrelin (n=27), nitrofen plus bombesin (n=27), nitrofen 
plus bombesin antagonist (n=27) and nitrofen plus ghrelin antagonist (n=27). 
The culture medium was replaced every 48 hours. Lungs were collected for 
Western blotting after 4 days in culture (96 h). 
 
Morphometric analysis 
Branching morphogenesis was monitored daily by photographing the 
explants using a stereomicroscope equipped with a camera (DP71, 
Olympus). At day 0 (D0: 0 h) and day 4 (D4: 96 h) of culture, branching, the 
epithelial and total perimeters, and the epithelial and total areas were 
measured using ImageJ image processing and analysis software (version 
1.44, Maryland, USA). 
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For all experimental conditions, the results were expressed as the D4/D0 
ratio.   
 
Western blotting   
Lung explants were processed for Western blot analysis using an RARα 
antibody at a 1:500 dilution, an RARβ antibody at a 1:200 dilution and an 
RARγ antibody (Santa Cruz Biotechnology Inc.) at a 1:500 dilution.  
Protein lysates of pooled lung explants (n=9) from each group were obtained 
via homogenisation of the foetal tissue with a pellet pestle motor (Kontes, 
Chicago, USA) as previously described (Nogueira-Silva et al., 2013). 
Different pooled lung samples were used, and three independent 
experiments were performed. Ten µg of protein was loaded onto 8% 
acrylamide minigels, and the procedure was performed as previously 
described (Piairo et al., 2011). The blots were incubated with RARα, RARβ 
or RARγ antibodies overnight at 4ºC, followed by an appropriate secondary 
anti-rabbit (1:5000 dilution) (Santa Cruz Biotechnology Inc.) or anti-mouse 
(1:2000 dilution) (Cell Signalling Technology) horseradish peroxidase-
conjugated antibody. The blots were subsequently developed with the Super 
Signal West Femto Substrate (Pierce Biotechnology), and the 
chemiluminescent signal was captured using a Chemidoc XRS system (Bio-
Rad, Philadelphia, USA). As a loading control, the blots were probed with a 
β-tubulin antibody (1:150,000 dilution; Abcam). Quantitative analysis was 
performed using Quantity One analysis software (version 4.6.5 1D, Bio-Rad). 
 
Statistical analysis 
All quantitative data are presented as the mean ± SEM. Statistical analysis 
was performed via one-way ANOVA using SigmaStat 3.5 (Systat Software 
Inc., California, USA). The Bonferroni test was applied for post-test analysis. 
The threshold for statistical significance was set at p<0.05. 
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RESULTS: 
 
RAR expression pattern in normal and hypoplastic 17.5 dpc rat lungs 
Immunohistochemistry analyses revealed that RARα, β and γ were 
expressed in the epithelial and mesenchymal cells of both control and 
hypoplastic lungs (Figure 1). Moreover, RARα and RARγ expression 
appeared to be higher in hypoplastic lungs than in control lungs (Figure 1). 
 
Bombesin, ghrelin, RA, bombesin plus RA and ghrelin plus RA 
supplementation analyses  
To evaluate the effects of neuroendocrine factors (bombesin and ghrelin), RA 
and bombesin or ghrelin plus RA on lung growth, control and hypoplastic 
foetal lung explants were performed. Figure 2A shows representative 
examples of control foetal lung explants treated with bombesin (1 
µM), ghrelin (30 nM), RA (10-6 M), bombesin plus RA or ghrelin plus RA. In 
normal lungs, bombesin, ghrelin, RA and the combination of bombesin or 
ghrelin with RA appear to stimulate lung growth (Figure 2A). In fact, all of 
these compounds increased the total number of peripheral airway buds, and 
bombesin, RA, bombesin plus RA and ghrelin plus RA also increased the 
epithelial perimeter (Figure 2B). Moreover RA increases the total area of the 
lungs (Figure 2B). 
In contrast, bombesin and ghrelin did not interfere with hypoplastic lung 
growth, as shown in Figure 2C and confirmed through morphometric analysis 
(Figure 2D). 
 
 
RAR protein expression after bombesin, ghrelin, bombesin plus RA and 
ghrelin plus RA supplementation  
To investigate the possible mechanisms underlying the effects of bombesin, 
ghrelin, and neuroendocrine factors plus RA interactions, the protein levels of 
RARα, β and γ were assessed. RARα and RARγ expression levels were 
higher in untreated hypoplastic lungs than in control lungs (Figure 3A, C). 
Bombesin and ghrelin supplementation induced RARα and RARγ expression 
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in normal lungs (Figure 3A, C). Bombesin plus RA and ghrelin plus RA also 
induced RARα expression (Figure 3A). In contrast, ghrelin-treated 
hypoplastic lungs exhibited decreased RARα and RARγ expression (Figure 
3A, C). The expression of RARβ was similar in all of the studied groups 
(Figure 3B). 
 
Effect of RA on RAR expression in normal foetal lungs 
To assess the effect of RA on RARα, β and γ, the levels of these three 
proteins were evaluated. In control lungs, RA led to decreased RARα and 
RARγ expression but increased RARβ expression (Figure 4). 
 
Effects of bombesin and ghrelin antagonists on normal and hypoplastic 
lung growth and RAR expression 
To confirm the roles of bombesin and ghrelin in normal and hypoplastic lung 
development, antagonists of these peptides were added to lung explants. 
The bombesin and ghrelin antagonists significantly inhibited lung growth, as 
indicated by decreases in the total number of peripheral airway buds and the 
epithelial perimeter (Figure 5 and 7A). However, the total area remained 
unchanged after treatment with the antagonists (data not shown). Regarding 
RAR protein expression, explants treated with the bombesin and ghrelin 
antagonists exhibited a statistically significant decrease in RARα expression 
(Figure 6A and 7B). In contrast, RARβ expression in treated explants was 
similar to that in untreated explants, and a slight decrease in RARγ 
expression was observed in explants treated with these antagonists (Figure 
6B, C and 7B, C). 
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DISCUSSION:  
 
Congenital diaphragmatic hernia (CDH) is associated with pulmonary 
hypoplasia, and it has been shown that RA signalling is involved in the 
establishment of this disease. Furthermore, CDH has been linked to 
increased levels of neuroendocrine factors. This report describes a putative 
link between neuroendocrine factors and the RA pathway in normal and 
hypoplastic lung development for the first time. 
Retinoids such as vitamin A and its derivatives are crucial for growth, 
development and tissue differentiation (Blomhoff and Blomhoff, 2006). RA 
acts by binding to nuclear receptors that exist in 3 different isoforms: α, β and 
γ (Mactier and Weaver, 2005). RA receptors are expressed from the earliest 
stages of embryonic lung development into postnatal life. RARα is 
ubiquitously expressed at consistent levels over time during lung 
development, whereas RARβ is excluded from the distal epithelium during 
branching but is still present in the epithelial cells of proximal and midsized 
airways (Wongtrakool et al., 2003; Roth-Kleiner and Post, 2005). In this 
study, we show that in the canalicular stage, RARs are expressed in 
epithelial and mesenchymal cells in both normal and hypoplastic lungs; 
moreover, the levels of RARα and RARγ appear to be increased in 
hypoplastic lungs, in contrast to what Rajatapiti (Rajatapiti et al., 2006) have 
been showed previously in qualitative analysis (Figure 1). 
Classically, RA is described as one of the major stimulators of lung 
development. In CDH, several growth factors, including RA, have been 
observed to promote lung branching when exogenously administered 
(Baptista et al., 2005, Keller et al., 2010). Furthermore, the RA signalling 
pathway has been shown to be involved in CDH pathogenesis and 
pulmonary hypoplasia. For instance, the incidence rate of CDH is higher in 
litters born to dams fed vitamin A-deficient diets (Andersen et al., 1941). 
RARα/RARβ double knockout mice display diaphragmatic hernia (Chen et 
al., 2003); however, when mutations affect only one isoform of one receptor, 
no foetal anomalies are detected, suggesting functional redundancy between 
various receptors and isoforms (Azais-Braesco and Pascal, 2000). Nitrofen 
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suppresses the RA response element (Major et al., 1998), and in vitro assays 
have shown that nitrofen inhibits RALDH2 (Mendelsohn et al., 1994). In 
humans, infants with CDH exhibit lower plasma retinol levels than healthy 
infants (Mey et al., 2003; Beurskens et al., 2007). Additionally, it has been 
demonstrated that antenatal administration of vitamin A reduces the 
incidence of CDH and restores lung maturation in the nitrofen rat model and 
that RA improves lung branching in CDH lungs in foetal lung explant cultures 
(Thébaud et al., 1999; Thebaud et al., 2001; Babiuk et al., 2004). 
Focusing on neuroendocrine cells, studies conducted during the last decade 
have revealed a complex functional role for PNECs. In the early stages of 
lung development, PNECs act as modulators of foetal lung growth and 
differentiation, whereas at the time of birth, they act mainly as airway O2 
sensors involved in neonatal adaptation (Andersen et al., 1941). The major 
neuroendocrine peptides in the lung are bombesin and ghrelin. Recent data 
from our group showed that ghrelin is overexpressed in human hypoplastic 
lungs and the lungs of CDH model rats compared with normal lungs (Santos 
et al., 2006). Bombesin expression has been shown to be higher in CDH 
lungs than in normal lungs (Cutz et al., 2007; Santos et al., 2006). These 
increases in some growth factors observed in CDH lungs might represent a 
compensatory response of hypoplastic lungs attempting to recover normal 
levels of lung growth (Santos et al., 2006). 
Given that PNECs behave as lung sensors and that RA is a classical lung 
growth factor and the levels of both neuroendocrine peptides and RA are 
affected in hypoplastic lungs, we hypothesised a putative link between these 
two important lung regulators.  
In the present study, it was demonstrated that bombesin, ghrelin and 
particularly RA or bombesin or ghrelin combined with RA promote normal 
lung branching and increase the lung epithelial perimeter (Figure 2A and 2B). 
Moreover, exogenous supplementation of bombesin or ghrelin in normal 
lungs increased RARα and RARγ expression but did not affect RARβ 
expression (Figure 3). In contrast, inhibition of bombesin or ghrelin 
decreased RARα and RARγ expression as well as lung branching (Figure 6 
and 5). Thus, these results demonstrate, for the first time, that there is a link 
between neuroendocrine factors and the RA signalling pathway. Moreover, 
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RARα and RARγ appear to be the major mediators between these two 
apparently different pathways. Indeed, these results suggest that the action 
of neuroendocrine factors during lung growth is at least mediated by an 
increase in RARα and RARγ expression, indicating that RA pulmonary 
sensitisation is mediated by neuroendocrine factors through RARα and 
RARγ.  
Furthermore, the results showed that RA supplementation in normal lungs 
decreased RARα and RARγ expression and increased RARb expression 
(Figure 4). A possible explanation for this observation is that neuroendocrine 
cells sense the increase in lung growth mediated by RA and consequently 
decrease the production of neuroendocrine factors, which in turn leads to 
decreased RARα and RARγ expression. However, the possibility of a direct 
down-regulation effect of RA on RAR expression cannot be excluded. RARβ 
expression was stimulated by RA supplementation and remained unchanged 
by bombesin and ghrelin modulation. These results exclude the involvement 
of RARβ in the RA/PNEC interaction with respect to lung growth 
mechanisms.  
Regarding pulmonary hypoplasia, according to the literature, RARα and 
RARγ are overexpressed in hypoplastic lungs compared with normal lungs. 
In vitro bombesin and ghrelin supplementation in hypoplastic lung explant 
cultures did not affect the examined lung morphometric parameters (Figure 
2B and 2D), probably because these receptors are already overexpressed. 
The expression of RARα and RARγ slightly decreases in hypoplastic lungs 
after ghrelin supplementation (Figure 3). We do not have a plausible 
explanation for this result. However, this finding reinforces the idea that there 
is an association between neuroendocrine factors and RA signalling. 
Moreover, inhibition of bombesin or ghrelin significantly decreased RARα 
expression as well as lung branching (Figure 7) reinforcing our hypothesis. 
It has largely been demonstrated that RA significantly increases lung 
branching in hypoplastic lungs after RA supplementation in vitro. Moreover, 
hypoplastic lungs overexpress bombesin and ghrelin (Cutz et al., 2007). In 
this study, we observed an increase in RARα and RARγ expression in 
hypoplastic lungs that might be explained by the compensatory 
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overexpression of bombesin and ghrelin in these lungs (Figure 3). This is in 
agreement with the effect of neuroendocrine factor supplementation in 
normal lungs. In Figure 8, a putative mechanism for the link between 
neuroendocrine cells and the RA pathway is presented.  
In summary, based on these results, we can conclude that neuroendocrine 
factors act as regulators of lung growth, sensitising the lungs to the action of 
RA through RARα and RARγ up-regulation. 
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Retinoic acid receptor (RAR) expression patterns in 17.5 days post 
conception rat lungs under normal and hypoplastic conditions. (A) RARα. (B) RARβ. 
(C) RARγ. (D) Negative immunohistochemistry controls - omission of the primary antibodies. 
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Figure 2 
 
 
 
 
Figure 2. Branching morphogenesis of rat lung explant cultures treated with bombesin 
(Bomb), ghrelin (Grl), retinoic acid (RA), bombesin plus RA (Bomb+RA) or ghrelin plus 
RA (Grl+RA). (A) The upper panel is representative of normal lung explants (CTR) at day 
zero (D0); the bottom panel represents untreated lung explants (CTR) and explants treated 
with DMSO, bomb, grl, RA, bomb plus RA or grl plus RA on day four (D4). (B) Morphometric 
analysis of the number of peripheral airway buds, epithelial perimeter and total area. (C) The 
upper panel is representative of the hypoplastic lung explants (N) at D0;  the bottom panel 
represents untreated hypoplastic lung explants (N) and hypoplastic explants treated with 
bomb or grl on D4. (D) Morphometric analysis of the number of peripheral airway buds, 
epithelial perimeter and total area. The results are expressed as the D4/D0 ratio. *p<0.05; 
**p<0.01; ***p<0.001.  
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Figure 3 
 
 
Figure 3. Protein expression levels of retinoic acid receptors (RARs) in normal (Ctr) 
and hypoplastic (N) lung explants treated with bombesin (Bomb), ghrelin (Grl) as well 
as  bombesin plus RA (Bomb+RA) or ghrelin plus RA (Grl+RA) in normal lung 
explants. (A) RARα expression, (B) RARβ expression, (C) RARγ expression. Examples of 
representative blots are shown. Protein levels were normalised to β-tubulin, which was used 
as a loading control. The data are presented as the mean ± SE. *p<0.05; ** p<0.01; 
***p<0.001. 
 
 
 
Figure 4 
 
 
 
 
Figure 4. Protein expression levels of retinoic acid receptors (RARs) in normal lung 
explants (DMSO) treated with retinoic acid (RA). (A) RARα, (B) RARβ, (C) RARγ. 
Representative blots are shown. Protein levels were normalised to β-tubulin, which was used 
as a loading control. The data are presented as the mean ± SE. **p<0.01 vs. DMSO. 
 
 
Chapter IV Retinoic Acid and Neuroendocrine factors 
 86 
Figure 5 
 
Figure 5. Branching morphogenesis in rat lung explant cultures (Control) treated with 
a bombesin or ghrelin antagonist (Bomb Ant or Grl Ant). The number of peripheral 
airway buds and the epithelial perimeter. The results are expressed as the D4/ D0 ratio. *** 
p<0.001. 
 
 
 
Figure 6 
 
 
 
Figure 6. Protein expression levels of retinoic acid receptors (RARs) in normal lung 
explants (Control) treated with a bombesin or ghrelin antagonist (Bomb Ant or Grl 
Ant). (A) RARα, (B) RARβ, (C) RARγ. Representative blots are shown. Protein levels were 
normalised to β-tubulin, which was used as a loading control. The data are presented as the 
mean ± SE. **p<0.01; ***p<0.001. 
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Figure 7 
 
 
 
 
Figure 7. Branching morphogenesis and RAR expression levels of rat hypoplastic lung 
explant (N) cultures treated with a bombesin or ghrelin antagonist (Bomb Ant or Grl 
Ant). (A) The number of peripheral airway buds, epithelial perimeter and total area. Results 
are expressed as the D4/ D0 ratio. * p<0.05. (B) RARα, RARβ, and RARγ protein expression 
levels. Representative blots are shown. Protein levels were normalised to β-tubulin, which 
was used as a loading control. The data are presented as the mean ± SE. *p<0.05; 
**p<0.01. 
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Figure 8 
 
 
 
Figure 8. Schematic representation of the putative link between neuroendocrine cells 
and the retinoic acid signalling pathway. In the upper panel, on left side of the scheme 
we have represented the normal foetal lung expressing neuroendocrine products: Bombesin 
(Bomb) and Ghrelin (Grl) as well as Retinoid acid receptors (RAR). On right side of the 
scheme we have represented the CDH foetal lungs, which express increased (↑) levels of 
neuroendocrine products (Bomb and Grl) as well as RAR. On the bottom panel, we 
represent the RAR explants expression after modulation (agonists and antagonists) of 
neuroendocrine products. Focusing on isoform alfa (α), in control explants, RAR(α) 
expression is significantly increased (↑) and decreased (↓) with addition of agonists (full 
arrows, Bomb and Grl) and antagonists (dashed arrows, Bomb Ant and Grl Ant) of 
neuroendocrine products, respectively. Regarding CDH explants, addition of neuroendocrine 
products does not induce and additional increment of RAR(α) expression when compared 
with untreated CDH explants (=), but addition of neuroendocrine antagonists (Bomb Ant and 
Grl Ant) induces a significant decrease (↓) of RAR(α) expression. These findings make us to 
propose a mechanism of interaction between bombesin and ghrelin with the retinoic acid 
signalling pathway through the modulation of RAR expression that seems to be working in 
the hypoplastic lungs. 
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D ISCUSSION 
 
Lung development is a complex process that involves different 
signalling pathways (for recent review see McCulley D, et al., 2015). In order 
to understand abnormal lung development it is crucial to know normal foetal 
lung growth. There are several pathologies including bronchopulmonary 
dysplasia, lung fibrosis, pulmonary hypertension and congenital 
diaphragmatic hernia that result from abnormal lung development.  
This PhD thesis, aimed to understand and to investigate the role of 
novel regulatory pathways in foetal lung such as ephrins (Chapter II) and 
microRNAs (Chapter III). Additionally, neuroendocrine and retinoic acid 
pathways were revisited as they are two out of four well-known regulators of 
lung growth, and a putative regulatory link between them was determined 
(Chapter IV). 
Little is known about ephrins and lung development. There are just two 
papers associating ephrins with lung morphogenesis and repair (Vadivel A, 
et al., 2012; Bennett KM, et al., 2013). However, ephrins have been strongly 
associated with vascular system development, capillary remodelling, 
alveologenesis, microvascular maturation and angiogenesis (Wang HU, et 
al., 1998; Adams RH, et al., 1999; Gale NW, et al., 2001; Shin D, et al., 
2001). Ephrins have already been described in other branching organs such 
as kidney, pancreas and mammary gland (Nikolova Z, et al., 1998; 
Takahashi T, et al., 2001). On the other hand, ephrin B1 –B2 and eph B4 
knockout mice die before birth and develop several anomalies including 
angiogenic and lung alveolar formation impairment such as enlarged 
airspaces (Adams RH, et al., 2001; Davy A, et al., 2004; Wilkinson GA, et al., 
2008). Moreover, in vivo knockdown of ephrin B2 arrests alveolar and 
vascular growth, and in vivo supplementation attenuates pulmonary 
hypertension (Vadivel A, et al., 2012). Considering, ephrins B1 –B2 and eph 
B4 importance during development and embryogenesis, its role during 
normal foetal lung growth as new potential lung growth regulators was 
assessed.   
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In our study, we observed by Immunohistochemistry and Western Blot 
analysis that ephrin B1, -B2 and eph B4 receptor are expressed during all 
gestational ages in lung development, with no differences between stages of 
foetal lung growth. This result suggests their potential role in all stages of 
foetal lung development. Interestingly, ephrin B1 is essentially expressed in 
the mesenchyme / vascular cells whereas ephrin B2 and eph B4 receptor are 
expressed in the epithelium, which might indicate that ephrins are involved in 
both processes: airway and vasculature branching, acting synergistically. In 
this study, when ephrin B1 and –B2 were administrated to lung explants, 
there was an increase in lung branching and growth reinforcing their role, 
namely in early stages of lung development (pseudoglandular stage). 
Moreover, ephrin B2 effects, lead to ERK, JNK and STAT3 signalling 
pathways inhibition in contrast to ephrin B1. This inhibition can be context 
dependent or an indirect effect of the activation of other signalling pathways. 
A possible explanation to the fact that there are no changes in the expression 
of this signalling pathways once ephrin B1 is administrated, might be the fact 
that ephrin B1 may be acting in other signalling pathways such as Sonic 
Hedgehog (Shh), RA, Bmp or FGF and does not lead to any alteration on the 
signalling pathways studied (Correia-Pinto J, et al., 2010; Moura RS, et al., 
2011; Moura RS, et al., 2014). It would be interesting to check weather 
inhibition of ERK, JNK and STAT3 are a direct consequence of ephrin B2 
administration. In vivo studies with administration of ephrin B1 and –B2 could 
be done in CDH lungs in order to check if it improves foetal lung branching 
and reduces lung hypoplasia. 
However, lung growth induced by exogenously ephrins administration in 
normal lungs has not biological relevance. In fact, there is no dose effect 
growth and the smaller dose already contributes to the differences observed 
between control and treated lung explants. Indeed, the higher doses do not 
contribute to higher increases in lung growth (no dose dependent effect).  
In conclusion this study showed that ephrins and eph B4 receptor are 
important in foetal lung development and contribute to lung morphogenesis 
and branching. However, ephrins do not seem to be a key regulator of lung 
growth and they seem to act as a morphogen on lung development, or a 
vascular factor promoting lung vasculogenises. Indeed, a morphogen can be 
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considered a growth factor, but a growth factor is not necessarily a 
morphogen. In this sense, FGF, Bmps, Shh, Wnt are morphogens, because 
they promote in vitro lung development and growth, but when they are used 
in vivo (intraparenchymal microinjections) they just promote locally growth 
causing anomalies and cystic adenomatoid malformations (Gonzaga S, et 
al., 2008). On the other hand, RA, neuroendocrine factors and angiotensin 2 
seem to be growth factors, because in vitro they promote harmonious lung 
growth (Babiuk RP, et al., 2004; Santos M, et al., 2006; Nunes S, et al., 
2008; Nogueira-Silva C, et al., 2012b). 
For these reasons, a new field of research on lung development namely 
epigenetics and more specifically microRNAs was assessed, in normal and 
CDH foetal lung development (Chapter III). CDH is a lung disease strongly 
associated with high mortality and morbidity rates and pulmonary 
hypertension. Until now there is no specific genetic cause or molecular 
alteration that is responsible for CDH (Veenma DC, et al., 2012).  
As a PhD in Health Sciences with a master dissertation on genetics, 
searching and looking for a group where it is possible to deal with both fields, 
CDH and microRNAs, became an interest. In Canada, new highlights that 
can be useful using microRNAs as a new prognostic biomarker in CDH 
patients were found (Chapter III).  
There are several studies reporting microRNAs as potential 
therapeutical targets in cancer research and also their use as biomarkers for 
cancer detection. Moreover microRNAs have been described to be important 
in numerous processes, including EMT and branching morphogenesis that 
are crucial during lung development and embryogenesis (Gregory PA, et al., 
2011; Mujahid S, et al., 2013; Liu W, et al., 2014; Liu W, et al., 2015). 
There is growing evidence that TGF-β/ZEB/miR-200 signalling network, 
regulates the establishment and maintenance of EMT and ZEB / miR-2OO 
balance, resulting in switching the cells between epithelial and mesenchymal 
states (Gregory PA, et al., 2011). In fact, in a cell recombinant model for 
nitrofen-induced abnormal lung development in vitro it was shown a 
disturbed fibroblast/epithelial cell ratio in nitrofen-induced lung hypoplasia 
(van Loenhout RB, et al., 2012).  
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By microarray analysis, 319 human microRNAs were scanned and a 
significant increase in the expression of miR-200b and miR-10a in CDH 
human lung tissue was observed when compared to normal lung tissue. After 
these interesting findings on microRNA signature and their confirmation by 
RT-qPCR, neonatal human postmortem lung tissue was used to do in situ 
hybridization and immunohistochemistry analysis. In situ hybridization 
showed that miR-200b expression was higher in the distal part of postnatal 
hypoplastic lungs when compared to normal lungs, which fits with the RT-
qPCR and microarray previously done. Moreover TGF-β2 was assessed by 
immunohistochemistry as a target gene of miR-200b. TGF-β2 was decreased 
in CDH lungs when compared to normal lungs and miR-200b was increased, 
which corroborates with previous data reported in cancer research (Burk U, 
et al., 2008; Gregory PA, et al., 2011).  
Moreover, a commercial human bronchial epithelial cells line (BEAS) 
was used to measure SMAD-induced gene expression, in order to establish 
the inhibitory effect of miR-200b on TGF-β/SMAD signalling in human BEAS. 
In human BEAS, SMAD and phospho SMAD activities, increased when 
miR-200b decreased (administration of miR-200b inhibitor) and the opposite 
occurred when miR-200b was added (miR-200b mimics). Moreover ZEB2 
(target gene for miR-200b) also increases when miR-200b is inhibited, and it 
decreases when miR-200b is administrated to normal BEAS. These results 
corroborate previous described data and showed a strong correlation 
between ZEBs and TGF-β2. Additionally, they exhibited negative correlations 
between miR-200 and TGF-β2, and between miR-200 and ZEBs. Moreover, 
it has been described that overexpression of miR-200b is associated with an 
epithelial phenotype (increased E-cadherin) and inhibition of miR-200b is 
associated with a more mesenchymal phenotype (decreased E-cadherin) 
(Park SM, et al., 2008). In figure 5, a summary of the main results on BEAS 
assay is shown. 
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Figure 5. Schematic representation of the proposed mechanism for regulating human 
lung EMT / MET. 
 
An interesting finding of this study was the fact that miR-200b 
expression was increased in CDH human lungs when compared to normal 
lungs, in opposition to what was described by Van Loenhout et al. 2012 in rat 
lungs. Moreover, TGF-β2 was increased after FETO in a CDH sheep model 
(Quinn TM, et al., 1999; van Loenhout RB, et al., 2012). A possible 
explanation for that might be the use of nitrofen to induce CDH in rats 
because in humans it may have different origins (nitrofen does not induce 
CDH). Moreover, the surgical model to induce CDH in sheep’s, does not lead 
to the abnormal lung hypoplasia observed in CDH rat and human lungs, 
before the diaphragmatic defect. Additionally the only study published refers 
to in vitro lung epithelial and mesenchymal cells from CDH rats, and not to 
lung tissue and consequently the cells can change the production of different 
molecules or microRNAs to regulate / promote growth and development (van 
Loenhout RB, et al., 2012). 
Meanwhile, we got amniotic and tracheal fluid samples from patients 
with severe CDH conditions that underwent FETO, responders and non-
responders patients, were analysed. Because of the significant differences 
found in the microarray of CDH and normal lung tissue, miR-200 family and 
miR-10a expression was checked in these two fluids. Regarding the tracheal 
fluid before FETO there were no differences in miR-200 family expression 
between responders and non-responders, however miR-10a was higher in 
non-responders and did not increase after FETO, in opposite to what happen 
in responders. After FETO, responders presented higher expression of miR-
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200 and miR-10a than non-responders. This can be useful to predict the 
outcome of these patients in the future. However one of the limitations in this 
study is the fact that there was not any control samples of the tracheal fluid 
from normal patients, because it is an invasive process, and all this results 
need to be validated in a large sample set before being used in pre-clinical 
studies. 
It would be interesting to further elucidate and refine this hypothesis, to 
investigate combinations of foetuses displaying lung growth alterations 
(evidenced by increase in ultrasound lung measurements) with different 
microRNA signatures, and on the other hand, foetuses without obvious lung 
growth response on ultrasound, but with a responsive microRNA signature.  
Considering the amniotic fluid samples, expression of miR-200 family 
and miR-10a in amniotic fluid was decreased after FETO and was always 
lower than tracheal fluid expression. This interesting finding indicates that 
microRNAs in those patients form the largest component of the amniotic fluid 
because after FETO they decrease in the amniotic fluid and increase in the 
tracheal fluid. In fact, it is described that lungs contribute largely to the 
amniotic fluid content in the third trimester of pregnancy (Evrard VA, et al., 
1997). On the other hand, responders to FETO generally presented higher 
expression of miR-200 family and miR-10a in the amniotic fluid before plug 
than non-responders, so, these findings can be useful in future pre-clinical 
studies in order to use these microRNAs as biomarkers in the amniotic fluid 
to predict CDH outcome. 
In the future, CDH and normal rat lung tissue will be studied during 
gestation in order to characterize the expression patterns of miR-200b, TGF-
β2 and ZEB2.  
As future perspectives, if miR-200b emerges as having a crucial role in 
CDH and consequently improves lung growth, maturation and development 
of human CDH patients, it can be used as a pre-natal therapy to help those 
patients. The idea is to quantify miR-200 and miR-10a expression in amniotic 
fluid, and to predict the prognosis for CDH patients. If the levels are lower 
than in the survivors, once FETO is done, miR-200 can be administrated into 
the lungs when the plug is inserted. Although, studies regarding doses will be 
crucial because overexpression or down-regulation of microRNAs are 
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strongly associated with cancer development and metastasis (Muller S, et al., 
2015; Vychytilova-Faltejskova P, et al., 2015; Wong CM, et al., 2015). 
Another interesting experiment would be analysing CDH lung tissue from 
responders and non-responders in order to check miR-200b and TGF-β2 
expression, and correlate them with what was observed in the tracheal fluid. 
This study will strongly contribute to find potential biomarkers that can be 
useful as prognostic tools for CDH patient’s outcome. In summary, these 
findings might be useful in the future as potential prognostic tool rather than a 
potential therapy. 
After studying two new different signalling pathways in normal lung 
growth and development regulation (Chapter II and III), two different 
signalling pathways already known to be crucial and altered in foetal normal 
and abnormal lung development were studied (Chapter IV). 
There are several studies reporting CDH in animal models and the best 
model to mimic human CDH is the nitrofen rat model (Correia-Pinto J, et al., 
2003; Ruttenstock E, et al., 2011), justified by the fact that the lungs before 
being compressed by the abdominal organs are already hypoplastic. The 
underlying mechanisms are still unknown and a better understanding of 
these mechanisms will help to find a potential therapy. An important finding 
on CDH lungs is the capacity of catch-up growth regulation, that is the ability 
of the lungs to recover to normal lung growth when they are relieved from the 
mechanical compression and they grow in vitro (Nogueira-Silva C, et al., 
2008). Moreover, a small increase in lung parenchyma can be crucial in the 
adaptation of CDH foetus to extra-uterine life (Santos M, et al., 2006). 
Recently published data has shown that there are few molecular 
disturbances on CDH rat lungs at the level of vitamin A and neuroendocrine 
products. RA is essential for normal lung development and for diaphragm 
development as well (Ross SA, et al., 2000). Looking into the literature, there 
are several articles reporting the association between nitrofen and RA 
disruption. RA has been described as down regulated on CDH rat lungs, and 
pregnant rats with a deficient diet on vitamin A result in a high rate of CDH 
new-borns (Clugston RD, et al., 2006; Coste K, et al., 2015). Moreover, 
prenatal treatment with RA promotes alveologenesis, increases the gas 
exchange surface area, lung growth and branching morphogenesis on CDH 
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rat lungs, attenuating lung hypoplasia (Ruttenstock E, et al., 2011). In fact, 
the disruption on RA signalling pathway on CDH rat lungs has been largely 
associated with a decrease in plasma retinol and retinol-binding protein 
levels. Moreover the inhibition of RALDH2 induced by nitrofen is a secondary 
consequence of nitrofen administration. Furthermore, vitamin A has 
teratogenic properties and in CDH human lungs, its deficit is detected late on 
gestation, around 16 weeks, which limits its use as a potential therapy 
because it acts early on gestation (Baptista MJ, et al., 2005). Regarding RAR 
and RXR knockouts, RAR α/ RARβ double knockout mice presented lung 
agenesis, hypoplasia and / or diaphragmatic defects and for this reason only 
RAR receptors were studied (Mendelsohn C, et al., 1994) (Chapter IV).  
Concerning neuroendocrine factors, in CDH lungs there is a pulmonary 
neuroendocrine cell hyperplasia, which consequently leads to bombesin and 
ghrelin increase, in humans and in animal models. Additionally it is known 
that branching organs such as kidneys, lungs and stomach are the main 
sources of circulating foetal ghrelin. Interestingly ghrelin knockout mice do 
not show lung abnormalities, although ghrelin is increased on CDH rat lungs 
(Sun Y, et al., 2003; Santos M, et al., 2006). Moreover in vivo administration 
of bombesin to nitrofen pregnant dams, decreased lung hypoplasia on CDH 
embryos (Sakai K, et al., 2014). Published data also shows that exogenous 
administration of ghrelin to nitrofen pregnant rats, attenuate pulmonary 
hypoplasia on CDH lungs (Santos M, et al., 2006; Nunes S, et al., 2008). 
However, the changes observed in CDH lungs concerning RA, 
bombesin and ghrelin expression are not well understood and the underlying 
mechanisms still remain unclear. In order to better clarify all this changes and 
mechanisms, a correlation between these two apparently different and not 
related signalling pathways was identified (RA vs neuroendocrine factors). In 
this study, by immunohistochemistry we observed at the end of canalicular, 
beginning of saccular stages, higher expression of RAR (mesenchymal and 
epithelial) in hypoplastic lungs when compared to normal lungs. However, 
Rajatapiti et al., have previously shown by immunohistochemistry that, there 
were no differences between these two groups. In fact, 
immunohistochemistry is a qualitative technique so we confirmed our results 
by Western Blot (Rajatapiti P, et al., 2006). With the administration of 
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bombesin, ghrelin, RA, RA plus bombesin and RA plus bombesin to normal 
foetal lung explant cultures, an increase in the morphometric parameters 
analysed was observed, mainly in the number of peripheral airway buds and 
epithelial perimeter. RA was the major stimulator in lung growth and RA 
combined with neuroendocrine factors, even promoted higher growth, than 
when they were administrated alone. This result suggests that they are 
acting in a different way to promote lung growth and branching when 
exogenously administrated. Moreover by Western blot RAR α / γ expression 
increase in normal lung explants after bombesin and ghrelin administration 
has confirmed, the action of PNEC as potential sensors in lung growth 
(Santos M, et al., 2006). On the other hand, when RA was administrated to 
the cultures, RAR α / γ expression decreased and RAR β increased. This can 
be explained by the fact that neuroendocrine cells sense that increase and 
decreased bombesin and ghrelin production, which consequently leads to a 
decrease in RAR α / γ expression. Another possible explanation can be a 
direct down-regulation effect of RA on RAR expression. This results show 
that there is a link between neuroendocrine factors and RA where RAR α 
and RAR γ develop the major roles and RAR β is apparently excluded from 
this interactions. Consequently these in vitro studies suggest that RAR α and 
RAR γ expression strongly sensitize for CDH pathology. 
Moreover, according to this study, when RA is administrated in 
combination with bombesin or ghrelin, RAR α expression increases and 
nothing happens to the other receptors. This can be explained by the fact 
that RA administration decreases RAR expression, and neuroendocrine 
factors increases RAR expression in normal lungs, so together, the effect of 
each one of them cancel the effect of the other. Indeed with this experiment, 
the interactions between bombesin or ghrelin and RA were confirmed.  
Concerning inhibitory studies, bombesin and ghrelin were inhibited in 
normal lung explants, and RAR expression was evaluated. Once again RAR 
α and RAR γ expression was decreased and branching was also reduced 
which reinforce the idea that neuroendocrine factors sensitize RA through 
RAR α and RAR γ.  
Chapter V General Discussion 
 100 
Regarding hypoplastic lungs, RAR α / γ expression was increased when 
compared to normal lungs which was expected because hypoplastic lungs 
already had and increase in bombesin and ghrelin as described above. 
Additionally when bombesin or ghrelin were administrated to hypoplastic 
lungs, there were no changes in morphometric parameters probably because 
this PNEC stimulatory effect is already on the limit, whereas RAR α and RAR 
γ expression decreased. The increase on ghrelin and bombesin on CDH rat 
lungs can be a consequence of lung immaturity or a compensatory response 
of the hypoplastic lung attempting to recover to normal levels of lung growth 
(Santos M, et al., 2006). These results suggest once again the strong link 
between RA and neuroendocrine factors. In the same trend bombesin and 
ghrelin inhibition, decreased RAR α / γ expression as well as lung branching 
in hypoplastic lung explants.  
Interestingly, in this study RAR α and RAR γ are the major mediators 
involved in RA/PNEC interactions, however knockout mice that resulted in 
hypoplastic lungs are RAR α / RAR β double knockouts (Mendelsohn C, et 
al., 1994; Beurskens LW, et al., 2009). A possible explanation for that can be 
RAR redundancy because simple RAR knockout mice do not result in lung 
pathologies. When one isoform of RAR (α, β or γ) is knockdown, lungs look 
healthy, so the other two isoforms can compensate that inhibition and lungs 
grow and develop normally. 
In future studies it would be interesting to see the expression of 
bombesin and ghrelin in those knockouts and to compare them with normal 
and nitrofen-induced lungs. On the other hand, it would also be interesting to 
block in vivo bombesin and ghrelin in pregnant rats and see what happens to 
RAR expression in the lungs of the foetus. Another important thing to 
understand would be to explore why neuroendocrine factors are up-regulated 
on CDH rat lungs? Is it a cause or a consequence of the disease?  
In summary this study showed that neuroendocrine factors act as 
regulators of lung growth, sensitizing the lungs to the action of RA through 
RAR α and RAR γ up-regulation, contributing to understand the underlying 
mechanisms of these two apparently different signalling pathways.  
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With these work, potential prenatal therapies emerged, such as the use 
of RA and neuroendocrine factors in CDH babies. Regarding RA as a 
prenatal therapy for human CDH patients, it as a lot of complications 
because of RA teratogenicity. However, bombesin and ghrelin administration 
to CDH babies can be a potential prenatal therapy to attenuate lung 
hypoplasia without apparently any adverse effect. 
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CONCLUSIONS 
 
Having in mind the overall aim of the present PhD thesis, to find new 
prenatal therapeutical approaches to revert foetal lung hypoplasia in CDH 
context, the main conclusions are listed bellow. 
- Ephrin B1, -B2 and eph B4 receptor are constitutively expressed in 
foetal lung during gestation, promoting lung growth when exogenously 
administrated (ephrin B1 and ephrin B2). However the increase in branching 
growth is smaller than 20% of normal lung growth, which does not represent 
a big increase considering in vivo studies. This findings suggests that ephrins 
does not seem to be a promisor mechanism to regulate lung growth. 
Although, they can be strong candidates to act as morphogens or being 
involved in vascular regulation regarding foetal lung development. 
- MicroRNA signature is changed in CDH human lungs when compared 
to healthy lungs; specifically miR-200b and miR-10a are increased. After 
FETO miR-200 family and miR-10a significantly increases in the tracheal 
fluid of responders to FETO. These results can be useful as using 
microRNAs as prognostic biomarkers for CDH outcome. 
- Two out of four strongly studied signalling pathways (retinoic acid and 
neuroendocrine factors), known to promote normal foetal lung growth were 
shown to be correlated: ghrelin and bombesin act as regulators of lung 
growth, preparing the lungs to the action of RA through RARα and RARγ up-
regulation.  
 
In Figure 6 a schematic picture of the main results of this PhD work are 
presented. According to the aims proposed important mechanisms involved 
in normal and abnormal lung growth regulation, were found and some of 
these findings might be used in the future in pre-natal therapies in order to 
increase the quality of life of CDH patients. Moreover, microRNAs have the 
potential to be used as biomarkers to predict CDH outcome in humans.  
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Figure 6. Schematic representation of changes found in important regulators of lung 
growth: normal versus CDH rat and human lungs 
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